https://www.pharmaceutical-business-review.com/news/enterome-enters-drug-discovery-collaborations-with-janssen-and-takeda-080116-4771218/ 2016-01-08T01:32:00+00:00 https://www.pharmaceutical-business-review.com/news/uniqures-gene-therapy-increases-clotting-in-two-hemophilia-b-patients-080116-4771726/ 2016-01-08T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-wins-fda-approval-to-study-tb-403-for-treatment-of-pediatric-brain-tumors-080116-4771754/ 2016-01-08T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-biosys-sanofi-deutschland-partner-to-develop-medicines-for-metabolic-disorders-080116-4771761/ 2016-01-08T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/arrowhead-doses-first-patient-in-phase-2b-monarch-combination-study-of-arc-520-080116-4771766/ 2016-01-08T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-abbvies-snda-for-viekira-pak-080116-4771781/ 2016-01-08T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-checkpoint-therapeutics-sign-license-agreement-for-oral-parp-inhibitor-080116-4771792/ 2016-01-08T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/kymab-md-anderson-form-cancer-drug-discovery-and-development-alliance-080116-4772083/ 2016-01-08T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovance-unveils-three-clinical-trials-to-support-advanced-development-of-centanafadine-080116-4772102/ 2016-01-08T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/report-says-safer-drugs-will-increase-vasculitis-treatment-market-value-to-558m-by-2024-080116-4772117/ 2016-01-08T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/apogenix-receives-first-milestone-payment-from-canbridge-licensing-agreement-080116-4772147/ 2016-01-08T06:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-innate-pharma-partner-to-develop-new-bispecific-antibodies-in-immuno-oncology-110116-4772691/ 2016-01-11T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-to-support-moderna-in-clinical-development-of-mrna-therapeutics-110116-4772783/ 2016-01-11T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-invests-46m-into-early-stage-research-companies-110116-4773431/ 2016-01-11T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/akashi-therapeutics-partners-with-grnenthal-group-on-ht-100-for-duchenne-muscular-dystrophy-110116-4773548/ 2016-01-11T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-makes-equity-investment-in-kairos-therapeutics-110116-4773765/ 2016-01-11T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-plans-to-start-phase-3-study-for-zalviso-in-q1-110116-4773774/ 2016-01-11T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-starts-ind-enabling-studies-of-novel-bi-specific-monoclonal-antibody-110116-4773789/ 2016-01-11T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-and-baxalta-agree-on-32bn-merger-120116-4774061/ 2016-01-11T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-collaborates-with-moderna-incyte-for-new-cancer-treatments-120116-4774251/ 2016-01-12T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-warp-drive-bio-expand-cancer-drug-research-collaboration-120116-4774950/ 2016-01-12T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/enbrel-proposed-biosimilar-chs-0214-meets-primary-endpoint-in-phase-3-study-120116-4775247/ 2016-01-12T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-starts-enrollment-of-six-phase-3-studies-for-pan-genotypic-hepatitis-c-regimen-120116-4775252/ 2016-01-12T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/aaa-inks-deal-with-johns-hopkins-university-to-develop-psma-receptor-ligand-in-prostate-cancer-120116-4775267/ 2016-01-12T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/celator-pharmaceuticals-to-participate-in-cardiff-university-clinical-irial-in-adults-with-aml-120116-4775273/ 2016-01-12T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/sorrento-karolinska-institutet-partner-to-perform-immuno-oncology-research-120116-4775283/ 2016-01-12T07:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eagle-pharmaceuticals-amri-sign-deal-to-jointly-develop-parenteral-drug-products-120116-4775291/ 2016-01-12T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-acquires-uk-drug-discovery-firm-iomet-pharma-120116-4775334/ 2016-01-12T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-venetoclax-leukaemia-drug-accepted-for-review-in-us-and-europe-130116-4775584/ 2016-01-13T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-submits-tenofovir-alafenamide-nda-in-us-for-chronic-hbv-infection-130116-4783583/ 2016-01-13T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-merck-to-study-drug-combination-for-treatment-of-pancreatic-cancer-130116-4783626/ 2016-01-13T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-expands-immuno-oncology-pipeline-through-collaboration-with-surface-oncology-130116-4783902/ 2016-01-13T06:59:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cytori-therapeutics-signs-deal-with-idis-to-launch-managed-access-program-in-emea-130116-4783913/ 2016-01-13T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pluristems-ind-to-start-clinical-trial-of-of-plx-r18-130116-4783925/ 2016-01-13T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ionis-completes-target-enrollment-in-phase-3-cherish-study-in-children-with-spinal-muscular-atrophy-130116-4783935/ 2016-01-13T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-achieves-milestone-in-targetad-collaboration-with-janssen-in-alzheimers-disease-130116-4783940/ 2016-01-13T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/chinas-fda-accepts-to-review-casis-marqibo-130116-4783949/ 2016-01-13T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/delmar-md-anderson-partner-to-accelerate-development-of-val-083-anti-cancer-drug-140116-4784298/ 2016-01-14T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-starts-phase-1-study-of-ionis-hbv-lrx-to-treat-hepatitis-b-virus-140116-4784774/ 2016-01-14T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/us-ftc-clears-galapagos-and-gileads-global-partnership-on-filgotinib-140116-4784824/ 2016-01-14T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-biomedica-wins-uk-mhra-approval-to-manufacture-bulk-drug-material-at-yarnton-plant-140116-4784886/ 2016-01-14T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-eortc-partner-to-investigate-triptorelin-for-treatment-of-salivary-gland-cancers-4784900/ 2016-01-14T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-enrolls-first-patient-in-phase-ii-circle-study-140116-4784908/ 2016-01-14T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cepheid-forms-diagnostic-collaboration-with-medimmune-and-combacte-140116-4784922/ 2016-01-14T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/syros-pharmaceuticals-closed-40m-financing-of-preferred-stock-140116-4784939/ 2016-01-14T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/therakine-cell-care-therapeutics-sign-license-and-development-deal-150116-4785213/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/turing-receives-no-objection-letter-from-health-canada-to-start-tur-002-program-clinical-study-150116-4786469/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/amri-signs-collaboration-deal-with-new-york-center-for-nanomedicine-research-150116-4786488/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neurovive-pharmaceutical-acquires-minority-stake-in-isomerase-therapeutics-140116-4785050/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-starts-clinical-trial-of-oral-selinexor-in-advanced-liposarcoma-150116-4785120/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-starts-phase-23-trial-of-imetelstat-in-myelodysplastic-syndromes-150116-4785179/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/boehringer-ingelheim-arena-pharmaceuticals-partner-to-advance-research-in-schizophrenia-150116-4785208/ 2016-01-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-two-new-indications-for-novartis-cosentyx-psoriasis-drug-180116-4785769/ 2016-01-18T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-bioepis-enbrel-biosimilar-secures-european-commission-approval-180116-4786325/ 2016-01-18T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/patient-dies-in-phase-1-clinical-trial-of-bials-drug-in-france-180116-4786454/ 2016-01-18T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/hutchison-medipharma-starts-hmpl-523-phase-i-clinical-trial-in-haematological-cancer-in-australia-180116-4786594/ 2016-01-18T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/nivalis-therapeutics-gets-fda-orphan-drug-designation-for-n91115-in-cystic-fibrosis-180116-4786633/ 2016-01-18T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/strategia-starts-phase-1-study-of-ff-21101-in-patients-with-advanced-cancers-180116-4786656/ 2016-01-18T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/globaldata-says-shires-acquisition-of-baxalta-marks-strong-start-to-healthcare-mergers-and-acquisitions-for-2016-180116-4786698/ 2016-01-18T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/ixico-wins-four-new-contracts-from-pharmaceutical-companies-and-biotechnology-firm-180116-4786754/ 2016-01-18T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-status-to-eisais-snda-for-anticancer-drug-lenvatinib-190116-4787073/ 2016-01-19T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/centauri-acquires-immuno-therapeutics-platform-technology-from-altermune-190116-4787702/ 2016-01-19T05:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/santhera-signs-distribution-deal-with-ewopharma-for-raxone-190116-4787818/ 2016-01-19T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/international-consortium-secures-eurostars-grant-to-develop-novel-treatment-for-clotting-disorders-190116-4788007/ 2016-01-19T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-rare-pediatric-disease-designation-to-medicinovas-mn-166-to-treat-krabbe-disease-190116-4788024/ 2016-01-19T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/graham-boulnois-appointed-as-chairman-of-medicines-technologies-catapult-190116-4788033/ 2016-01-19T07:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/hepatocellular-carcinoma-treatment-market-will-rise-to-550m-by-2024-report-says-200116-4790577/ 2016-01-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-therapeutics-to-buy-biotie-therapies-for-363m-200116-4788451/ 2016-01-20T01:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ec-approves-baxaltas-oncaspar-as-combination-therapy-in-all-200116-4788940/ 2016-01-20T05:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cellectis-inks-deal-with-cellforcure-for-cgmp-manufacturing-of-ucart123-200116-4788984/ 2016-01-20T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-submits-nda-to-fda-for-oral-once-daily-baricitinib-to-treat-moderate-to-severe-ra-200116-4789235/ 2016-01-20T07:15:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dynavax-astrazeneca-amend-existing-deal-for-asthma-drug-candidate-200116-4789241/ 2016-01-20T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovia-uk-university-partner-to-validate-early-detection-blood-test-for-pancreatic-cancer-200116-4789264/ 2016-01-20T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-enrolls-265-patients-in-aura-study-of-voclosporin-in-active-lupus-nephritis-200116-4789272/ 2016-01-20T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/eyegate-enrolls-first-patient-in-phase-3-trial-egp-437-006-for-non-infectious-anterior-uveitis-200116-4789280/ 2016-01-20T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-launches-entresto-heart-failure-drug-in-uk-210116-4789588/ 2016-01-21T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cymabay-completes-end-of-phase-2-talks-with-fda-for-arhalofenate-gout-candidate-210116-4790034/ 2016-01-21T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/zafgens-beloranib-obesity-drug-succeeds-in-phase-3-trial-210116-4790112/ 2016-01-21T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/globaldata-says-pulmonary-arterial-hypertension-therapy-market-will-hit-475bn-by-2024-210116-4790564/ 2016-01-21T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-neovacs-propose-to-form-jv-to-manufacture-conjugated-therapeutic-vaccines-210116-4790589/ 2016-01-21T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/oncogenex-provides-update-on-phase-2-spruce-trial-in-previously-untreated-metastatic-nsclc-210116-4790597/ 2016-01-21T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-venetoclax-receives-fda-breakthrough-therapy-designation-210116-4790606/ 2016-01-21T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-combination-therapy-involving-amgens-kyprolis-cancer-drug-220116-4790773/ 2016-01-21T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-depression-drug-fails-to-meet-primary-endpoints-in-two-trials-220116-4790992/ 2016-01-22T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/drug-companies-urge-governments-to-join-fight-on-superbugs-220116-4791072/ 2016-01-22T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cleveland-biolabs-entolimod-wins-orphan-drug-status-from-ema-as-radiation-countermeasure-220116-4791365/ 2016-01-22T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/vtv-therapeutics-starts-phase-2-trial-evaluating-ttp273-to-treat-type-2-diabetes-220116-4791374/ 2016-01-22T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/asterias-transfers-ast-vac2-manufacturing-process-to-cancer-research-uk-220116-4791385/ 2016-01-22T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/vasopharm-raises-eur20m-to-advance-treatment-for-traumatic-brain-injury-220116-4791394/ 2016-01-22T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/optum-parexel-partner-to-reduce-drug-development-costs-related-with-post-approval-studies-220116-4791402/ 2016-01-22T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oxeia-advances-development-of-oxe-103-to-treat-concussions-220116-4791414/ 2016-01-22T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nephrogenex-announces-independent-dsmb-recommendation-to-continue-oral-pyridorins-phase-3-study-220116-4791425/ 2016-01-22T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-opdivos-melanoma-approval-to-include-braf-mutant-patients-250116-4792170/ 2016-01-25T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-vectibix-phase-3-study-meets-primary-endpoint-250116-4792664/ 2016-01-25T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-acquires-dyax-for-59bn-250116-4792713/ 2016-01-25T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-botox-to-treat-lower-limb-spasticity-in-adults-250116-4793052/ 2016-01-25T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/national-cancer-institute-selects-pathcore-for-cancer-informatics-development-250116-4793057/ 2016-01-25T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/broad-institute-genomic-services-partners-with-takeda-to-perform-genomic-analysis-on-patient-samples-from-phase-3-clinical-trial-of-ninlaro-250116-4793063/ 2016-01-25T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-universities-global-pharma-firms-launch-therapeutics-research-fund-250116-4792944/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/medigene-partners-with-swiss-university-to-characterize-t-cell-receptors-250116-4793014/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ixchelsis-achieves-positive-clinical-poc-for-ix-01-to-treat-premature-ejaculation-260116-4793043/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xtl-gets-encouraging-feedback-from-fda-on-ind-filing-for-lupus-drug-hcdr1-260116-4793072/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-acquires-generic-retin-a-portfolio-from-matawan-pharmaceuticals-250116-4793076/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-acceptance-of-bla-submission-for-brodalumab-in-moderate-to-severe-plaque-psoriasis-250116-4793081/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/encore-vision-completes-enrollment-in-clinical-study-evaluating-topical-ev06-to-treat-presbyopia-250116-4793088/ 2016-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-approves-boehringers-ofev-to-treat-idiopathic-pulmonary-fibrosis-270116-4793786/ 2016-01-27T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-experimental-bowel-drug-fails-to-meet-end-point-in-phase-2a-study-270116-4794386/ 2016-01-27T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/virginia-resident-tests-positive-for-mosquito-borne-zika-virus-270116-4794475/ 2016-01-27T05:29:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-completes-biofronteras-ameluz-nda-mid-cycle-review-270116-4794507/ 2016-01-27T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ono-pharmaceutical-expands-adoption-of-medidata-clinical-cloud-platform-270116-4794517/ 2016-01-27T05:42:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pharnext-partners-with-orphandev-for-phase-3-trial-of-pxt-3003-to-treat-cmt-1a-270116-4794537/ 2016-01-27T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/oracle-unveils-new-solution-connecting-research-pathology-and-clinical-care-270116-4794568/ 2016-01-27T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-mercks-bezlotoxumab-c-difficile-antitoxin-280116-4795237/ 2016-01-28T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-stops-phase-2-sub-study-on-ruxolitinib-to-treat-colorectal-cancer-280116-4795649/ 2016-01-28T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-neos-therapeutics-adzenys-xr-odt-adhd-drug-280116-4795691/ 2016-01-28T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/stemedica-cell-technologies-completes-enrollment-in-phase-iiia-study-for-ischemic-stroke-280116-4795706/ 2016-01-28T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/genticel-unveils-initial-results-of-phase-2-trial-of-gtl001-hpv-immunotherapeutic-candidate-280116-4795729/ 2016-01-28T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/myeloma-uk-partners-with-sgc-to-accelerate-discovery-of-myeloma-treatment-targets-280116-4795743/ 2016-01-28T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/radius-health-partners-with-novartis-to-evaluate-rad1901-combination-regimens-in-advanced-breast-cancer-280116-4795760/ 2016-01-28T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/avera-medical-epic-sciences-partner-on-cancer-precision-medicine-clinical-trials-290116-4798438/ 2016-01-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-deems-exelixis-nda-for-cabozantinib-to-treat-advanced-renal-cell-carcinoma-290116-4798449/ 2016-01-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/who-says-zika-virus-cases-could-reach-4-million-290116-4796508/ 2016-01-29T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-plans-to-increase-presence-in-iran-290116-4796598/ 2016-01-29T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/rigel-completes-patient-enrollment-in-first-phase-3-study-of-fostamatinib-in-itp-290116-4796963/ 2016-01-29T04:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bristol-myers-squibbs-phase-3-opdivo-head-and-neck-cancer-study-stopped-early-290116-4796981/ 2016-01-29T04:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-breakthrough-therapy-designation-to-lynparza-for-prostate-cancer-290116-4796990/ 2016-01-29T04:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eib-lends-eur20m-to-french-biopharmaceutical-firm-transgene-290116-4797003/ 2016-01-29T04:58:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/abbvie-starts-enrollment-in-phase-3-clinical-study-for-elagolix-in-patients-with-uterine-fibroids-290116-4797020/ 2016-01-29T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-review-acadias-nuplazid-for-psychosis-in-parkinsons-disease-010216-4797752/ 2016-02-01T01:12:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/allergan-astrazeneca-sign-antibiotic-development-deal-010216-4798124/ 2016-02-01T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-recommends-approval-of-coagadex-to-treat-rare-bleeding-disorder-010216-4798177/ 2016-02-01T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/oxford-biomedica-starts-second-cart-programme-for-undisclosed-indication-010216-4798184/ 2016-02-01T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-adopts-positive-opinion-recommending-empliciti-to-treat-multiple-myeloma-010216-4798193/ 2016-02-01T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-completes-patient-enrollment-in-phase-2b3-us-dry-eye-trial-4798201/ 2016-02-01T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharmaceuticals-starts-registrational-trial-of-spi-2012-in-breast-cancer-010216-4798211/ 2016-02-01T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-gets-fda-nod-to-start-clinical-development-of-ap32788-020216-4798769/ 2016-02-02T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-launches-project-to-develop-vaccine-for-zika-virus-020216-4799150/ 2016-02-02T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-regulator-approves-human-gene-editing-technique-020216-4799247/ 2016-02-02T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-gileads-type-ii-variation-application-for-truvada-020216-4799263/ 2016-02-02T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/panacea-pharmaceuticals-selects-goodwin-to-develop-anti-cancer-monoclonal-antibody-020216-4799283/ 2016-02-02T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-pfizer-collaborate-with-portola-to-develop-andexanet-alfa-in-japan-020216-4799305/ 2016-02-02T04:53:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eisai-acquires-license-from-huya-to-develop-hdac-inhibitor-hbi-8000-020216-4799320/ 2016-02-02T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/matinas-gets-fda-nod-to-start-phase-1-study-of-mat2501-to-treat-ntm-infections-020216-4799655/ 2016-02-02T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-completes-enrollment-in-apollo-phase-3-study-with-patisiran-in-rare-protein-disorder-020216-4799668/ 2016-02-02T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/eagle-pharmaceuticals-wins-fda-fast-track-designation-for-ryanodex-to-treat-exertional-heat-stroke-020216-4799672/ 2016-02-02T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-cancer-drug-developer-mission-therapeutics-raises-60m-in-funding-round-030216-4800149/ 2016-02-03T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-adaptimmune-therapeutics-expand-cancer-immunotherapy-alliance-030216-4800646/ 2016-02-03T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/cloud-pharmaceuticals-completes-17-computational-drug-discovery-projects-030215-4800697/ 2016-02-03T05:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teva-and-abcellera-sign-deal-to-discover-rare-monoclonal-antibodies-030216-4800705/ 2016-02-03T05:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ligand-inks-omniab-platform-license-deal-with-tizona-therapeutics-030216-4800718/ 2016-02-03T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-for-nimbus-ndi-010976-to-treat-nash-030216-4800726/ 2016-02-03T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-complete-response-letter-to-telestas-bla-for-mcna-4800738/ 2016-02-03T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-firm-unveils-zika-vaccine-candidates-040216-4801360/ 2016-02-04T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/cytori-cell-therapy-found-safe-in-phase-i-erectile-dysfunction-trial-040216-4801757/ 2016-02-04T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fast-forward-pharmaceuticals-starts-phase-ii-trials-of-ffp104-anti-cd40-monoclonal-antibody-040216-4801795/ 2016-02-04T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/viacyte-acquires-rights-to-betalogics-assets-from-janssen-040216-4801807/ 2016-02-04T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-tagrisso-to-treat-patients-with-egfr-t790m-mutation-positive-nsclc-040216-4801818/ 2016-02-04T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/arch-biopartners-submits-ab569-orphan-drug-application-to-ema-040216-4801834/ 2016-02-04T04:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eisai-esteve-sign-deal-to-co-promote-anti-epilepsy-drug-fycompa-in-spain-040216-4801848/ 2016-02-04T04:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/takeda-secures-rights-to-mersanas-xmt-1522-outside-us-and-canada-040216-4802066/ 2016-02-04T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-indication-for-mercks-emend-nausea-and-vomiting-drug-050216-4802565/ 2016-02-05T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sigmoid-pharma-agrees-to-acquire-freund-pharmatec-050216-4803059/ 2016-02-05T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-enters-research-partnership-to-develop-mrsa-vaccine-050216-4803063/ 2016-02-05T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/aaicml-unveil-new-offering-for-solid-state-chemistry-and-formulation-development-050216-4803076/ 2016-02-05T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/juventas-enrolls-first-patient-in-phase-2-gene-therapy-clinical-trial-050216-4803092/ 2016-02-05T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-starts-phase-11b-clinical-trial-of-taladegib-in-combination-with-paclitaxel-050216-4803112/ 2016-02-05T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-advisory-committee-votes-in-favor-for-takeda-and-lundbecks-brintellix-050216-4803191/ 2016-02-05T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-unveils-commercial-and-regulatory-progress-under-adcetris-collaboration-with-takeda-050216-4803514/ 2016-02-05T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-declines-to-approve-vertexs-kalydeco-in-people-with-cystic-fibrosis-ages-2-and-older-080216-4803577/ 2016-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-signs-clinical-research-collaboration-agreement-with-mrk-080216-4804448/ 2016-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/affinivax-gets-additional-funding-to-advance-its-pneumococcal-vaccine-08022016-4804541/ 2016-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-squibbs-daklinzas-for-expanded-use-to-treat-patients-with-hepatitis-c-080216-4804556/ 2016-02-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-mda-partner-to-develop-novel-oral-disease-modifying-treatment-for-dmd-080216-4804048/ 2016-02-08T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-issues-draft-guidance-on-alirocumab-for-lipid-disorder-090216-4805171/ 2016-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/egalet-signs-agreement-with-septodont-090216-4805178/ 2016-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kodiak-sciences-partners-with-lonza-090216-4805190/ 2016-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-secures-40m-long-term-loan-facility-090216-4805199/ 2016-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/volpi-qiagen-team-up-to-manufacture-automated-fluorescence-imaging-module-090216-4805204/ 2016-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-imposes-partial-hold-on-cti-biopharmas-pacritinib-clinical-trial-090216-4805214/ 2016-02-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-drug-agency-establishes-task-force-to-fast-track-trials-on-zika-virus-090216-4804877/ 2016-02-09T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/cigna-and-aetna-sign-pay-for-performance-deal-with-novartis-for-entresto-drug-100216-4806164/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-delays-decision-on-sarepta-therapeutics-drug-to-treat-muscular-dystrophy-4806423/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-and-cytobioteck-extened-distribution-agreement-for-ruconest-100216-4806759/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/smc-accepts-treatments-for-breast-cancer-myeloma-and-adhd-100216-4806771/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-biopharma-exploring-possible-research-programs-in-zika-virus-100216-4806788/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tobira-therapeutics-completes-patient-recruitment-for-orion-phase-2a-study-of-cenicriviroc-100116-4806796/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cti-biopharma-provides-update-on-clinical-hold-of-investigational-agent-pacritinib-100216-4806830/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-announces-prostate-cancer-clinical-trial-results-100216-4806834/ 2016-02-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-health-agency-rejects-sanofis-cholesterol-drug-4805776/ 2016-02-10T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-halts-clinical-trial-of-cti-biopharmas-blood-cancer-drug-110216-4808304/ 2016-02-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-offers-to-buy-meda-in-72bn-transaction-110216-4807556/ 2016-02-11T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-plans-to-make-cheaper-alternative-to-retrophins-thiola-kidney-stone-drug-110216-4808140/ 2016-02-11T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-healthcare-selects-oracle-solutions-to-manage-clinical-monitoring-processes-110216-4808177/ 2016-02-11T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-achieves-50-enrollment-in-all-three-phase-3-studies-of-revefenacin-110216-4808186/ 2016-02-11T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-meets-with-fda-for-phase-2-clinical-trial-of-kevetrin-for-ovarian-cancer-110216-4808193/ 2016-02-11T06:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/lonza-renova-sign-manufacturing-deal-for-clinical-supply-of-rt-100-gene-therapy-110216-4808204/ 2016-02-11T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/amarantus-gets-fda-orphan-drug-designation-for-eltoprazine-to-treat-pd-lid-110216-4808210/ 2016-02-11T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-michigan-establishes-chronic-kidney-disease-consortium-with-pharma-firms-120216-4808805/ 2016-02-12T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-to-stop-janus-studies-of-ruxolitinib-in-solid-tumor-cancers-120216-4809270/ 2016-02-12T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-sandoz-application-for-biosimilar-to-amgens-neulasta-cancer-drug-120216-4809347/ 2016-02-12T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-completes-pharmacokinetic-study-with-bekinda-12-mg-formulation-120216-4809364/ 2016-02-12T05:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/crown-bioscience-to-commercialize-university-of-yorks-prostate-cancer-models-120216-4809379/ 2016-02-12T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/onl-therapeutics-gets-fds-orphan-drug-designation-for-onl1204-to-treat-retinal-detachment-120216-4809394/ 2016-02-12T05:29:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nanoviricides-inks-deal-with-university-of-pittsburgh-for-ocular-resting-of-drug-candidates-120216-4809407/ 2016-02-12T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-acquires-european-rights-to-pfizers-infliximab-biosimilar-150216-4810217/ 2016-02-15T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-suffers-set-back-in-alimta-vitamin-regimen-patent-lawsuit-in-uk-150216-4810788/ 2016-02-15T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/apellis-raises-47m-to-advance-immunotherapy-programs-150216-4810893/ 2016-02-15T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ennaid-therapeutics-prioritizes-zika-virus-rapid-drug-development-150216-4810908/ 2016-02-15T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-canada-recalls-certain-advil-pediatric-drops-and-childrens-advil-oral-suspension-products-150216-4810922/ 2016-02-15T05:54:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/philogen-expands-research-and-development-agreement-with-abbvie-150216-4811216/ 2016-02-15T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/essa-pharma-reports-financial-results-for-first-quarter-150216-4811229/ 2016-02-15T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-aranesp-blood-cell-disorder-drug-meets-primary-endpoint-in-phase-3-study-160216-4811651/ 2016-02-16T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-mercks-request-for-broader-use-of-zetia-and-vytorin-160216-4812121/ 2016-02-16T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/jhl-biotech-secures-approval-from-uks-mhra-to-start-clinical-trial-for-rituximab-biosimilar-160216-4812165/ 2016-02-16T05:16:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eisai-charles-river-laboratories-sign-collaboration-deal-for-new-drug-discovery-160216-4812193/ 2016-02-16T05:26:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/immunid-awarded-innovate-uk-grant-to-advance-immuntracker-assay-for-therapeutic-response-prediction-160216-4812210/ 2016-02-16T05:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mgb-biopharma-university-of-strathclyde-sign-deal-to-develop-novel-mgb-anti-infectives-160216-4812221/ 2016-02-16T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/cartiva-treats-first-patient-in-cartiva-sci-study-for-pain-associated-with-osteoarthritis-of-thumb-160216-4812231/ 2016-02-16T05:39:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-two-new-indications-for-gilead-sciences-harvoni-to-treat-chronic-hepatitis-c-170216-4813090/ 2016-02-17T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/flexion-meets-primary-endpoint-in-phase-3-trial-of-zilretta-in-knee-osteoarthritis-170216-4813606/ 2016-02-17T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-sets-guidelines-to-reduce-zika-virus-transmission-in-blood-supply-4813675/ 2016-02-17T05:08:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/merck-weizmann-institute-sign-new-framework-deal-on-research-collaboration-170216-4813692/ 2016-02-17T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/celators-phase-3-trial-of-vyxeos-in-patients-with-high-risk-aml-reaches-required-events-for-overall-survival-analysis-170216-4813704/ 2016-02-17T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/carmot-therapeutics-expands-drug-siscovery-collaboration-with-amgen-170216-4813715/ 2016-02-17T05:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eisai-piqur-sign-deal-to-investigate-halaven-and-pqr309-in-patients-with-tnbc-170216-4813734/ 2016-02-17T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/inovios-zika-vaccine-induces-immune-responses-in-preclinical-trial-180216-4814467/ 2016-02-18T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-wins-fda-breakthrough-therapy-status-for-durvalumab-cancer-drug-180216-4814698/ 2016-02-18T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-catalyst-pharmaceuticals-firdapse-new-drug-application-180216-4815131/ 2016-02-18T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/bluebird-bio-treats-first-patient-in-phase-1-study-of-bb2121-in-relapsedrefractory-multiple-myeloma-180216-4815185/ 2016-02-18T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-tarix-orphans-txa127-to-treat-congenital-muscular-dystrophy-180216-4815201/ 2016-02-18T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmaceutical-firm-synlogic-secures-40m-financing-180216-4815217/ 2016-02-18T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bone-therapeutics-treats-12-patients-without-safety-concerns-in-allob-phase-iia-spinal-fusion-trial-180216-4815227/ 2016-02-18T05:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/smoking-can-be-a-chronic-pain-in-your-neck-4815653/ 2016-02-18T10:11:00+00:00 https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-enrolls-250-patients-for-grass-pollen-allergy-trial-190216-4815370/ 2016-02-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/third-rock-ventures-launches-pliant-therapeutics-to-develop-therapies-for-fibrosis-190216-4815512/ 2016-02-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zafgens-beloranib-obesity-drug-meets-primary-efficacy-endpoint-in-phase-2b-trial-180216-4815555/ 2016-02-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-scientists-report-isolation-of-highly-potent-anti-ebola-virus-antibodies-from-recent-zaire-outbreak-190216-4816535/ 2016-02-19T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-pharmaceuticals-progresses-vascular-and-fibrotic-disease-platform-with-positive-top-line-phase-ia-data-on-soluble-guanylate-cyclase-stimulator-iw-1701-190216-4816555/ 2016-02-19T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/iliad-completes-randomized-study-groups-enrollment-in-phase-1b-trial-of-bpze1-pertussis-vaccine-220216-4817216/ 2016-02-22T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-wins-fda-breakthrough-therapy-status-for-pkc412-aml-treatment-220216-4817788/ 2016-02-22T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/effector-therapeutics-raises-series-b-financing-to-56m-220216-4817825/ 2016-02-22T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/strategia-starts-phase-1-trial-of-ff-10502-in-patients-with-advanced-cancers-220216-4817832/ 2016-02-22T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/titan-pharmaceuticals-unveils-notification-of-fda-action-date-extension-for-probuphine-220216-4817844/ 2016-02-22T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-briviact-to-treat-partial-onset-seizures-220216-4817863/ 2016-02-22T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-to-move-certain-functions-to-ireland-220216-4817870/ 2016-02-22T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-once-daily-hiv-drug-meets-primary-efficacy-endpoint-in-phase-3-study-230216-4818426/ 2016-02-23T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-snda-for-xtandi-in-mcrpc-230216-4819013/ 2016-02-23T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-partners-with-amgen-for-injectable-drug-delivery-systems-230216-4819055/ 2016-02-23T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-completes-transactions-to-buy-bms-rd-hiv-assets-230216-4819262/ 2016-02-23T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-launches-new-grants-program-to-support-hiv-cure-230216-4819273/ 2016-02-23T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-12-trial-of-vadastuximab-talirine-combination-therapy-for-patients-with-untreated-mds-230216-4819286/ 2016-02-23T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-sanofis-nda-for-fixed-ratio-combination-of-insulin-glargine-and-lixisenatide-230216-4819295/ 2016-02-23T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/formula-pharmaceuticals-rockland-immunochemicals-partner-to-develop-cik-car-immunotherapy-pipeline-230216-4819307/ 2016-02-23T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-selects-patheon-to-develop-drugs-using-intac-abuse-deterrent-formulations-technology-230216-4819319/ 2016-02-23T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/two-texas-hospitals-develop-rapid-tests-for-zika-virus-240216-4819879/ 2016-02-24T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-ptcs-application-for-translarna-dmd-drug-240216-4820317/ 2016-02-24T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-wins-fda-approval-for-makenas-single-dose-treatment-for-pregnant-women-240216-4820356/ 2016-02-24T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/juno-therapeutics-seattle-cancer-care-alliance-and-fred-hutch-create-new-immuno-oncology-clinical-trials-unit-240216-4820375/ 2016-02-24T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-unveils-results-from-first-study-to-evaluate-switching-to-ftaf-based-regimens-from-truvada-ftdf-based-regimens-240216-4820616/ 2016-02-24T07:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/neon-therapeutics-signs-collaborative-research-deal-with-netherlands-cancer-institute-240216-4820621/ 2016-02-24T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/gordagen-to-trial-new-drug-delivery-technology-from-monash-university-240216-4820627/ 2016-02-24T07:29:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-pfizers-xeljanz-xr-to-treat-rheumatoid-arthritis-250216-4821137/ 2016-02-25T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/forty-seven-completes-first-half-of-75m-financing-round-to-target-cancer-specific-antibodies-250216-4821299/ 2016-02-25T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/heart-surgeon-runs-to-work-every-day-for-30-years-4820710/ 2016-02-25T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-invests-in-us-oral-biologics-firm-rani-therapeutics-250216-4821592/ 2016-02-25T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-unveils-first-phase-ii-hiv-prevention-study-results-for-cabotegravir-250216-4821917/ 2016-02-25T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-and-grants-priority-review-for-allergans-avycaz-snda-250216-4821927/ 2016-02-25T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/retrophin-secures-european-orphan-drug-designation-for-re-024-to-treat-pantothenate-kinase-associated-neurodegeneration-250216-4821933/ 2016-02-25T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-agrees-to-acquire-two-cancer-care-companies-for-12bn-260216-4822561/ 2016-02-26T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-orphan-drug-status-for-acalabrutinib-for-three-indications-260216-4823041/ 2016-02-26T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/baxalta-precision-biosciences-partner-to-develop-car-t-therapies-260216-4823095/ 2016-02-26T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/could-exercising-be-bad-for-your-heart-4823197/ 2016-02-26T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-gileads-marketing-application-for-tenofovir-alafenamide-to-treat-chronic-hepatitis-b-260216-4823305/ 2016-02-26T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-1-trial-of-sgn-cd19b-for-patients-with-b-cell-non-hodgkin-lymphoma-260216-4823310/ 2016-02-26T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/medidatas-cloud-technology-powers-us-government-research-on-drug-development-costs-260216-4823317/ 2016-02-26T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/genomics-england-selects-icon-to-support-genome-sequencing-project-260216-4823325/ 2016-02-26T07:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-new-indication-for-novartis-afinitor-cancer-drug-290216-4823672/ 2016-02-29T00:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazenecas-brilique-gets-european-marketing-nod-to-treat-patients-with-history-of-heart-attack-290216-4824411/ 2016-02-29T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cellceutix-submits-spa-request-for-brilacidin-phase-3-trial-290216-4824467/ 2016-02-29T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-pharma-inks-licensing-deal-with-a-menarini-asia-pacific-for-spedra-avanafil-290216-4824685/ 2016-02-29T07:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/abbvie-receives-chmp-positive-opinion-for-viekirax-ombitasvirparitaprevirritonavir-tablets-exviera-dasabuvir-tablets-290216-4824700/ 2016-02-29T07:16:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-chmp-adopts-positive-opinion-for-gileads-fixed-dose-combination-descovy-to-treat-hiv-290216-4824748/ 2016-02-29T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/aldeyras-ns2-eye-drug-succeeds-in-phase-iia-study-in-allergic-conjunctivitis-010316-4825242/ 2016-03-01T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/is-there-any-stopping-super-lice-4825844/ 2016-03-01T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-tremelimumab-drug-fails-to-meet-survival-endpoint-in-mesothelioma-trial-010316-4825863/ 2016-03-01T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-removes-clinical-hold-on-respirerxs-cx1739-ampakine-drug-010316-4825913/ 2016-03-01T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-provides-update-on-two-phase-iii-studies-of-lebrikizumab-in-people-with-severe-asthma-010316-4826014/ 2016-03-01T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-says-ctp-656-solid-dose-phase-1-results-confirmed-superior-pharmacokinetic-profile-to-kalydeco-010316-4826029/ 2016-03-01T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/exelixis-ipsen-partner-to-develop-cabozantinib-in-regions-outside-us-canada-and-japan-010316-4826051/ 2016-03-01T05:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-committee-recommends-approval-of-giotrif-for-advanced-squamous-cell-cancer-of-lung-010316-4826067/ 2016-03-01T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-recommendations-to-reduce-risk-of-zika-virus-transmission-by-human-cell-and-tissue-products-020316-4830227/ 2016-03-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-sell-moventigs-european-marketing-rights-to-prostrakan-020316-4826864/ 2016-03-02T02:33:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/amgen-submits-supplemental-biologics-license-application-to-fda-for-blincyto-020316-4827455/ 2016-03-02T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gilead-sciences-odefsey-to-treat-hiv-1-infection-020316-4827532/ 2016-03-02T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-completes-dosing-in-phase-2-trial-of-prurisol-for-chronic-psoriasis-020316-4827546/ 2016-03-02T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-genentechs-sbla-to-extend-indication-of-xolair-in-allergic-asthma-to-pediatric-patients-020316-4827628/ 2016-03-02T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/savara-pharmaceuticals-closes-20m-series-c-financing-round-020316-4827636/ 2016-03-02T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/galmed-pharmaceuticals-enrolls-first-patient-in-arrive-study-020316-4827647/ 2016-03-02T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vitamin-d-during-pregnancy-strengthen-winter-babys-bones-4827791/ 2016-03-02T10:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mckesson-to-buy-canadian-drug-store-chain-rexall-health-for-22bn-030316-4827991/ 2016-03-03T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/two-uk-biotechnology-companies-form-immuno-oncology-joint-venture-030316-4828570/ 2016-03-03T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/robust-life-sciences-industry-to-drive-uk-pharmaceutical-market-to-43bn-by-2020-030316-4828888/ 2016-03-03T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-indication-for-astrazenecas-faslodex-fulvestrant-030316-4828923/ 2016-03-03T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-acquires-us-approved-totect-from-biocodex-030316-4828934/ 2016-03-03T06:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/motif-bio-doses-first-patient-in-iclaprim-phase-3-trials-to-treat-skin-infections-030316-4828944/ 2016-03-03T07:01:00+00:00 https://www.pharmaceutical-business-review.com/news/monkeys-drive-wheelchairs-using-only-their-thoughts-4829091/ 2016-03-03T09:35:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pfizer-merck-and-verastem-to-evaluate-avelumab-and-vs-6063-combination-for-ovarian-cancer-040316-4829537/ 2016-03-04T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmx-starts-phase-2-clinical-study-under-us-fda-ind-for-bpx-01-040316-4830045/ 2016-03-04T06:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/otonomy-starts-phase-2-trial-of-otiprio-in-pediatric-patients-with-aomt-040316-4830075/ 2016-03-04T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/portages-biohaven-orphan-drug-designation-request-granted-to-treat-spinocerebellar-ataxia-040316-4830208/ 2016-03-04T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ensemble-therapeutics-achieves-early-stage-research-milestone-in-drug-discovery-collaboration-with-alexion-040316-4830215/ 2016-03-04T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxart-starts-preclinical-testing-of-oral-zika-virus-vaccine-040316-4830224/ 2016-03-04T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/royalty-pharma-acquires-rights-to-uclas-xtandi-cancer-drug-for-114bn-070316-4830745/ 2016-03-07T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-csl-behrings-idelvion-to-treat-hemophilia-b-070316-4831085/ 2016-03-07T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-asthma-drug-nucalas-cosmos-study-demonstrates-safety-profile-070316-4831148/ 2016-03-07T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/remedy-completes-end-of-phase-2-meeting-with-fda-on-novel-drug-treatment-for-cns-related-edema-070316-4831161/ 2016-03-07T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/aimmunes-phase-2-follow-on-study-of-ar101-to-treat-peanut-allergy-shows-increased-desensitization-070316-4831178/ 2016-03-07T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ixekizumab-demonstrates-clinically-meaningful-improvements-as-early-as-one-week-among-moderate-to-severe-plaque-psoriasis-patients-070316-4831200/ 2016-03-07T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-imbruvica-for-first-line-treatment-of-chronic-lymphocytic-leukemia-070316-4831217/ 2016-03-07T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-labcentral-partner-to-support-biotech-startup-companies-080316-4836905/ 2016-03-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biocrysts-bcx4430-drug-improves-survival-rates-in-mice-infected-with-zika-virus-080316-4832233/ 2016-03-08T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-discontinues-phase-3-study-of-rintega-after-dsmb-recommendation-080316-4832303/ 2016-03-08T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-acquires-rights-to-boehringer-ingelheims-psoriasis-drug-for-595m-080316-4832529/ 2016-03-08T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-doses-first-patient-in-phase-2-trial-of-xmab5871-in-igg4-related-disease-080316-4832560/ 2016-03-08T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-announces-ridinilazole-preserves-gut-microbiome-of-patients-with-c-difficile-infection-in-phase-2-trial-080316-4832571/ 2016-03-08T04:59:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-fast-track-designation-for-medi8852-to-treat-patients-hospitalised-with-influenza-a-080316-4832582/ 2016-03-08T05:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/where-prostate-cancer-spreads-in-the-body-affects-survival-time-4832759/ 2016-03-08T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-mercks-sbla-for-keytruda-in-advanced-non-small-cell-lung-cancer-080316-4832971/ 2016-03-08T07:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-orphan-drug-designation-to-soricimeds-sor-c13-to-treat-ovarian-cancer-090316-4833649/ 2016-03-09T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/stealth-biotherapeutics-starts-phase-2-study-of-elamipretide-in-fuchs-corneal-endothelial-dystrophy-090316-4834057/ 2016-03-09T04:44:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sanofi-pasteur-merck-plan-to-end-joint-vaccines-operations-in-europe-090316-4834166/ 2016-03-09T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/tizona-therapeutics-completes-43m-series-b-financing-090316-4834178/ 2016-03-09T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-submits-maa-for-candidate-colorectal-cancer-therapy-to-european-medicines-agency-090316-4834188/ 2016-03-09T05:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/new-england-biolabs-selects-symmetry-for-sap-hana-cloud-migration-090316-4834201/ 2016-03-09T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-medimmunes-medi-551-neuromyelitis-optica-drug-100315-4835037/ 2016-03-10T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-lifts-partial-hold-on-medivations-pidilizumab-in-hematological-malignancies-100316-4835447/ 2016-03-10T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/immupharma-starts-patient-recruitment-process-in-lupuzors-phase-iii-clinical-trial-100316-4835463/ 2016-03-10T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-starts-phase-12-trial-for-aln-go1-to-treat-primary-hyperoxaluria-type-1-100316-4835474/ 2016-03-10T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-firm-aprea-closes-eur46m-series-b-financing-100316-4835486/ 2016-03-10T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-hcmc-and-university-of-minnesota-partner-on-nations-largest-concussion-brain-injury-study-100316-4835504/ 2016-03-10T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/grindeks-says-meldonium-should-not-be-included-in-prohibited-list-100316-4835798/ 2016-03-10T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-tevas-405bn-acquisition-of-allergans-generics-business-110316-4836123/ 2016-03-11T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-amgens-sbla-for-expanded-use-of-enbrel-drug-110316-4836519/ 2016-03-11T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/vericels-ixmyelocel-t-heart-drug-meets-primary-endpoint-in-phase-2b-clinical-trial-110316-4836556/ 2016-03-11T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-starts-phase-1b-basket-trial-of-rxdx-105-110316-4836565/ 2016-03-11T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/aspyrian-therapeutics-secures-40m-series-b-financing-110316-4836573/ 2016-03-11T05:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sri-international-wins-national-cancer-institute-contract-for-prevent-cancer-program-110316-4836580/ 2016-03-11T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/wistar-institute-and-phoremost-launch-drug-discovery-collaboration-110316-4836594/ 2016-03-11T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-seeks-additional-data-for-pas-for-allergans-restasis-multi-dose-bottle-110316-4836890/ 2016-03-11T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-secures-fda-approval-for-expanded-use-of-xalkori-cancer-drug-140316-4837525/ 2016-03-14T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-says-oxitecs-self-limiting-mosquito-pose-no-harm-to-humans-environment-140316-4837957/ 2016-03-14T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/sarilumab-found-superior-to-adalimumab-in-patients-with-active-ra-in-phase-3-study-140316-4838015/ 2016-03-14T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/actinium-pharmaceuticals-starts-pursuit-of-eu-orphan-designation-for-iomab-b-140316-4838027/ 2016-03-14T05:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/adc-doses-first-patient-in-phase-i-trial-of-adct-402-in-cd-19-positive-b-nhl-140316-4838031/ 2016-03-14T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/scancell-collaborates-with-research-team-at-karolinska-institutet-140316-4838040/ 2016-03-14T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-epidiolex-drug-reduces-childrens-seizures-in-phase-iii-trial-150316-4838724/ 2016-03-15T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/celators-vyxeos-leukemia-treatment-demonstrates-survival-benefit-in-phase-3-trial-150316-4839208/ 2016-03-15T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-aegleas-ind-application-for-aeb1102-to-treat-hematological-malignancies-150316-4839289/ 2016-03-15T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pronai-secures-fda-orphan-drug-designation-for-pnt2258-to-treat-dlbcl-150316-4839301/ 2016-03-15T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-to-review-sareptas-nda-for-eteplirsen-to-treat-duchenne-muscular-dystrophy-150316-4839314/ 2016-03-15T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ritter-pharmaceuticals-starts-phase-2b3-trial-of-rp-g28-in-lactose-intolerance-150316-4839327/ 2016-03-15T05:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-reviews-cancer-medicine-zydelig-4839344/ 2016-03-15T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-roches-atezolizumab-in-urothelial-carcinoma-160316-4840254/ 2016-03-16T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharmaceuticals-wins-fda-approval-for-evomela-for-use-in-two-multiple-myeloma-indications-160316-4840690/ 2016-03-16T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/orexigen-agrees-to-acquire-us-rights-to-contrave-obesity-pill-from-takeda-160316-4840746/ 2016-03-16T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/verona-pharma-unveils-positive-results-from-rpl554-dose-finding-study-160316-4840755/ 2016-03-16T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/reneuron-treats-first-patient-in-us-phase-iii-trial-in-blindness-causing-disease-retinitis-pigmentosa-160316-4840762/ 2016-03-16T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/repros-activates-process-for-securing-marketing-authorization-for-enclomiphene-160316-4840770/ 2016-03-16T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-consumer-healthcare-announces-availability-of-otc-childrens-flonase-allergy-relief-160316-4840782/ 2016-03-16T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-dice-molecules-collaborate-to-replace-injections-with-new-oral-medicines-170316-4841419/ 2016-03-17T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vitae-pharmaceuticals-vtp-43742-psoriasis-drug-succeeds-in-phase-2a-trial-170316-4841744/ 2016-03-17T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-miltenyi-biotec-forge-cell-and-gene-therapy-alliance-170316-4841813/ 2016-03-17T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/new-cancer-drugs-fund-provides-faster-access-to-effective-cancer-treatments-170316-4841841/ 2016-03-17T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-amends-protocol-for-phase-3-study-of-pv-10-in-treatment-of-locally-advanced-cutaneous-melanoma-170316-4841849/ 2016-03-17T04:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/inovio-signs-collaborative-research-deals-with-wistar-institute-for-dna-based-immunotherapies-170316-4841863/ 2016-03-17T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-biotech-inks-license-deal-to-deliver-genome-editing-technology-170316-4841875/ 2016-03-17T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/netflix-marathons-might-make-you-miserable-4834183/ 2016-03-17T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/beer-could-be-used-to-fight-cancer-and-disease-4839407/ 2016-03-17T08:50:00+00:00 https://www.pharmaceutical-business-review.com/news/tarantula-venom-could-be-used-in-painkillers-4840824/ 2016-03-17T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-secures-fda-approval-for-kovaltry-haemophilia-a-drug-180316-4842614/ 2016-03-18T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-advair-diskus-asthma-drug-achieves-primary-endpoint-in-study-180316-4843117/ 2016-03-18T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-genentech-partner-to-evaluate-kte-c19-and-atezolizumab-combination-in-nhl-180316-4843163/ 2016-03-18T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rules-favorably-on-efficacy-of-travivo-to-treat-major-depressive-disorder-180316-4843176/ 2016-03-18T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/kalytera-ramot-at-tel-aviv-university-to-study-novel-approach-to-treat-osteogenesis-imperfecta-180316-4843182/ 2016-03-18T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-pharmaceuticals-sells-antibiotic-assets-to-spero-therapeutics-180316-4843191/ 2016-03-18T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-elite-pharmaceuticals-sequestox-nda-180316-4843204/ 2016-03-18T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-xeljanz-rheumatoid-arthritis-drug-meets-endpoints-in-ulcerative-colitis-trials-210316-4843805/ 2016-03-21T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/pixarbio-unveils-usfda-opd-submission-of-nr-sci-for-orphan-drug-designation-for-spinal-cord-injury-210316-4844115/ 2016-03-21T04:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/theratechnologies-taimed-biologics-sign-distribution-deal-for-ibalizumab-210316-4844130/ 2016-03-21T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-eisai-unveil-revised-us-collaboration-for-cinv-franchise-210316-4844142/ 2016-03-21T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-ucb-unveil-positive-top-line-results-from-phase-3-study-evaluating-romosozumab-in-men-with-osteoporosis-4844152/ 2016-03-21T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-eagle-pharmaceuticals-kangio-blood-thinner-210316-4844368/ 2016-03-21T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/omnis-pharma-magnis-merge-to-form-clinical-stage-oncolytic-immunovirotherapy-development-firm-210316-4844414/ 2016-03-21T06:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/a-step-closer-to-a-male-birth-control-pill-4843127/ 2016-03-21T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/blueberries-could-help-fight-alzheimers-4844732/ 2016-03-21T10:21:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-zytiga-prostate-cancer-drug-220316-4844995/ 2016-03-22T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarins-phase-3-study-of-pegvaliase-meets-primary-endpoint-220316-4845266/ 2016-03-22T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-manchester-scientists-to-develop-zika-virus-vaccine-220316-4845333/ 2016-03-22T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-zhejiang-medicine-start-arx788-first-in-human-phase-i-trial-in-cancer-patients-220316-4845350/ 2016-03-22T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-elusys-anthim-monoclonal-antibody-anthrax-antitoxin-220316-4845363/ 2016-03-22T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/harvard-university-collaborates-with-merck-to-develop-novel-cancer-therapeutics-220316-4845376/ 2016-03-22T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/leo-pharma-gets-scientific-approval-of-enstilar-to-treat-psoriasis-in-eu-220316-4845394/ 2016-03-22T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-secures-fda-approval-for-psoriasis-drug-taltz-230316-4846490/ 2016-03-23T01:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/merck-wins-hepatitis-c-virus-drug-patent-case-against-gilead-230316-4846836/ 2016-03-23T04:32:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/moberg-pharma-cadila-sign-deal-for-late-stage-development-of-bupi-230316-4846895/ 2016-03-23T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-joins-the-human-vaccines-project-to-help-decode-the-immune-system-4846901/ 2016-03-23T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-spins-off-auto-immune-disease-company-as-topas-therapeutics-230316-4846907/ 2016-03-23T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/synairgen-unveils-positive-results-from-ongoing-collaboration-with-pharmaxis-230316-4846913/ 2016-03-23T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/vetter-breaks-ground-on-manufacturing-facility-in-germany-230316-4846921/ 2016-03-23T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-heart-drug-brilinta-fails-in-stroke-trial-230316-4847141/ 2016-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-and-sanofis-cholesterol-lowering-drug-study-meets-primary-endpoint-in-phase-3-trial-230316-4847184/ 2016-03-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-review-pfizers-maa-for-xeljanz-to-treat-moderate-to-severe-rheumatoid-arthritis-240316-4847819/ 2016-03-24T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/stanford-sri-to-support-development-of-novel-drugs-to-treat-triple-negative-breast-cancer-240316-4847855/ 2016-03-24T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-tevas-cinqair-asthma-injection-240316-4847863/ 2016-03-24T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-allergan-launch-otc-store-brand-equivalent-to-mucinex-1200mg-er-tablets-240316-4847872/ 2016-03-24T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-oxigenes-ca4p-to-treat-neuroendocrine-tumors-280316-4848304/ 2016-03-28T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-says-it-had-no-duty-to-develop-less-harmful-aids-drug-in-motion-to-dismiss-ahf-lawsuit-280316-4848785/ 2016-03-28T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/onxeo-acquires-dna-therapeutics-280316-4848828/ 2016-03-28T05:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/orig3n-sharp-edge-form-drug-discovery-alliance-280316-4848860/ 2016-03-28T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/infacare-completes-phase-iib-multicenter-development-program-for-stannsoporfin-280316-4848867/ 2016-03-28T05:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/puracap-pharmaceutical-acquires-blu-pharmaceuticals-and-blu-caribe-280316-4848875/ 2016-03-28T05:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/regeneron-bayer-to-jointly-develop-novel-combination-therapy-for-eye-diseases-280316-4848885/ 2016-03-28T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/forge-therapeutics-and-active-motif-form-epigenetics-research-collaboration-290316-4849627/ 2016-03-29T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-eagle-pharmas-seven-year-orphan-drug-exclusivity-for-bendeka-blood-cancer-drug-290316-4850053/ 2016-03-29T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-medicinal-product-status-to-eigers-ubenimex-for-pulmonary-arterial-hypertension-290316-4850103/ 2016-03-29T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ligand-signs-omniab-platform-license-agreement-with-abba-therapeutics-290316-4850112/ 2016-03-29T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/biondvax-completes-patient-enrolment-in-phase-2b-trial-of-m-001-universal-flu-vaccine-candidate-290316-4850127/ 2016-03-29T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-aralez-pharmaceuticals-nda-for-yosprala-290316-4850140/ 2016-03-29T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-ultram-extended-release-tablets-in-us-290316-4850149/ 2016-03-29T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-panel-backs-acadias-nuplazid-to-treat-parkinsons-disease-related-psychosis-300316-4850840/ 2016-03-30T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-brintellix-label-expansion-for-cognitive-dysfunction-300316-4851429/ 2016-03-30T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-wins-patent-trial-against-allergan-in-lialda-patent-case-in-us-300316-4851485/ 2016-03-30T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/oncbiomune-signs-mou-for-jv-with-vitel-to-develop-novel-cancer-vaccine-for-mexico-and-latin-america-300316-4851503/ 2016-03-30T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-pharmaceuticals-to-cut-25-of-headquarter-positions-300316-4851514/ 2016-03-30T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/herantis-pharma-secures-european-orphan-designation-of-cdnf-to-treat-als-300316-4851523/ 2016-03-30T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-secures-japanese-approval-for-tagrisso-lung-cancer-treatment-300316-4851536/ 2016-03-30T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ftc-seeks-additional-data-on-160bn-pfizer-allergan-merger-310316-4852173/ 2016-03-31T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-bristol-myers-squibbs-application-for-expanded-use-of-opdivo-cancer-drug-310316-4852521/ 2016-03-31T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-signs-three-year-contract-extension-for-cscs-total-regulatory-solutions-as-a-service-310316-4852605/ 2016-03-31T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-dynavaxs-bla-for-heplisav-b-adult-hepatitis-b-vaccine-310316-4852628/ 2016-03-31T05:25:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/rich-pharmaceuticals-extends-cro-deal-with-theradex-to-manage-clinical-sites-in-us-310316-4852638/ 2016-03-31T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-secures-preliminary-approval-for-clinical-trial-of-brilacidin-for-ulcerative-proctitis-310316-4852650/ 2016-03-31T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/aramchol-demonstrates-significant-anti-fibrotic-effect-in-pre-clinical-model-of-fatty-liver-disease-310316-4852668/ 2016-03-31T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-jazz-pharmaceuticals-defitelio-to-treat-hepatic-veno-occlusive-disease-310316-4852697/ 2016-03-31T05:46:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dr-reddys-acquires-ex-asia-rights-to-eisai-anti-cancer-agent-e7777-010416-4853568/ 2016-04-01T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-discontinues-fulranumab-phase-3-development-program-in-osteoarthritis-pain-010416-4853905/ 2016-04-01T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-identify-structure-of-zika-virus-010416-4853955/ 2016-04-01T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-venture-fund-invests-in-amal-therapeutics-to-develop-novel-therapeutic-colorectal-cancer-vaccine-010416-4853967/ 2016-04-01T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/humanwell-healthcare-and-puracap-pharmaceutical-to-buy-epic-pharma-010416-4853975/ 2016-04-01T06:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/array-biopharma-asahi-kasei-pharma-collaborate-for-novel-pain-and-inflammation-program-010416-4853988/ 2016-04-01T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-completes-in-vitro-study-in-support-of-planned-phase-2-trial-of-kevetrin-for-ovarian-cancer-4853998/ 2016-04-01T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/eu-committee-backs-approval-of-gsks-strimvelis-gene-therapy-for-rare-immune-disorder-040416-4854797/ 2016-04-04T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/injectable-eczema-drug-dupilumab-meets-primary-endpoints-in-two-phase-3-studies-040416-4855291/ 2016-04-04T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/supernus-pharmaceuticals-selects-dsg-to-support-two-adhd-phase-3-clinical-studies-040416-4855322/ 2016-04-04T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/rigel-completes-enrollment-of-fit-phase-3-program-for-fostamatinib-in-itp-040416-4855330/ 2016-04-04T05:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/quantum-pharmaceutical-signs-five-year-contract-extension-with-aah-pharmaceuticals-040416-4855340/ 2016-04-04T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/taihos-tas-102-meets-primary-endpoint-of-improving-overall-survival-in-phase-iii-study-in-patients-with-refractory-mcrc-040416-4855350/ 2016-04-04T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-wins-positive-chmp-opinion-for-opdivo-in-combination-with-yervoy-to-treat-advanced-melanoma-040416-4855359/ 2016-04-04T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-to-acquire-nimbus-apollo-in-12bn-deal-050416-4855990/ 2016-04-05T01:40:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ixico-to-support-clinical-trial-for-parkinsons-drug-oxb-102-050416-4856533/ 2016-04-05T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotechs-xilonix-marketing-application-granted-accelerated-review-in-europe-050416-4856608/ 2016-04-05T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/psychogenics-drug-discovery-collaboration-with-sunovion-achieves-milestone-050416-4856619/ 2016-04-05T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/citius-pharmaceuticals-acquires-leonard-meron-biosciences-050416-4856633/ 2016-04-05T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/capricor-therapeutics-says-dsmb-recommends-to-continue-hope-duchenne-clinical-trial-050416-4856640/ 2016-04-05T05:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/portola-pharmaceuticals-inks-deal-with-daiichi-sankyo-to-develop-andexanet-alfa-with-edoxaban-050416-4856651/ 2016-04-05T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-biosimilar-of-jjs-remicade-drug-to-treat-autoimmune-diseases-060416-4857405/ 2016-04-06T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/sareum-cancer-drug-candidate-wins-uk-mhra-clinical-trial-approval-060416-4857945/ 2016-04-06T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reportedly-terminates-160bn-merger-with-allergan-060416-4858024/ 2016-04-06T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/braeburn-camurus-reach-enrollment-goals-in-two-phase-3-trials-of-cam2038-to-treat-opioid-dependence-060416-4858045/ 2016-04-06T06:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ani-pharmaceuticals-oxycodone-hcl-capsules-5mg-060416-4858065/ 2016-04-06T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-plans-to-discontinue-development-of-iw-9179-for-gastroparesis-060416-4858071/ 2016-04-06T06:26:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nantbioscience-nantkwest-partner-with-nci-to-further-develop-recombinant-nk-cells-and-monoclonal-antibodies-060416-4858095/ 2016-04-06T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-expands-opdivo-approval-for-lung-and-kidney-cancer-070416-4858720/ 2016-04-07T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-partners-with-heptares-to-develop-treatments-for-neurological-disorders-070416-4859166/ 2016-04-07T05:12:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/johnson-johnson-to-develop-tesaros-prostate-cancer-candidate-niraparib-070416-4859246/ 2016-04-07T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lumos-pharma-raises-34m-in-series-b-financing-070416-4859260/ 2016-04-07T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-acquires-rights-from-lilly-to-develop-ruxolitinib-to-treat-graft-versus-host-disease-070416-4859276/ 2016-04-07T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-pharmstandard-sign-cooperation-agreements-in-russia-070416-4859285/ 2016-04-07T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/remd-biotherapeutics-doses-first-type-1-diabetes-patient-with-remd-477-070416-4859300/ 2016-04-07T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-revolade-for-children-with-chronic-itp-070416-4859642/ 2016-04-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-backs-accelerated-approval-of-intercepts-ocaliva-liver-drug-080416-4859874/ 2016-04-08T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-adopts-chmp-recommendation-to-change-terms-of-marketing-authorisation-for-ruconest-080416-4859876/ 2016-04-08T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-adaptimmunes-nda-for-affinity-enhanced-t-cell-therapy-targeting-afp-in-liver-cancer-080416-4859878/ 2016-04-08T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-galapagos-start-phase-1-study-in-joint-antibody-program-mor106-080416-4859880/ 2016-04-08T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/juno-wuxi-apptec-launch-new-cancer-immunotherapies-company-in-china-080416-4859882/ 2016-04-08T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-eli-lilly-continue-trial-of-azd3293-alzheimers-drug-after-positive-safety-data-110416-4860244/ 2016-04-11T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-anavex-3-71-to-treat-frontotemporal-dementia-110416-4860747/ 2016-04-11T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-subcutaneous-route-of-administration-in-binocrits-nephrology-indication-110416-4860796/ 2016-04-11T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-leidos-partner-to-develop-zika-virus-vaccine-candidate-110416-4860809/ 2016-04-11T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-places-clinical-hold-on-late-stage-study-on-ionis-ttrrx-110416-4860828/ 2016-04-11T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacytes-encapsulation-facility-for-pancreatic-cancer-therapy-deemed-suitable-by-thai-fda-110416-4860839/ 2016-04-11T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheims-giotrif-secures-new-nsclc-licence-in-europe-110416-4860849/ 2016-04-11T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-venclexta-for-tough-to-treat-type-of-leukemia-120416-4861560/ 2016-04-12T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-starts-phase-ii-study-of-bekinda-for-irritable-bowel-syndrome-120416-4861998/ 2016-04-12T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-begins-phase-3-trial-of-epidiolex-in-seizure-associated-genetic-disorder-120416-4862041/ 2016-04-12T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-acquires-majority-stake-in-nitin-lifesciences-120416-4862056/ 2016-04-12T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/nmt-pharmaceuticals-inks-licensing-deal-with-cao-pharma-on-anti-cancer-drug-cz-48-120416-4862083/ 2016-04-12T06:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tobira-therapeutics-dong-a-st-sign-license-agreements-for-evogliptin-and-cenicriviroc-120416-4862092/ 2016-04-12T06:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mylan-announces-us-launch-of-generic-lopressor-tablets-375-mg-and-75-mg-120416-4862106/ 2016-04-12T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-pharmaceuticals-apd371-pain-drug-succeeds-in-early-stage-test-130416-4862844/ 2016-04-13T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-launches-otc-store-brand-equivalent-to-glucerna-aseptic-adult-nutritional-shake-130416-4863066/ 2016-04-13T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/oracle-offers-cloud-solution-to-help-enhance-drug-safety-130416-4863300/ 2016-04-13T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-appilis-ati-1501-to-treat-c-difficile-in-children-130416-4863332/ 2016-04-13T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/eusa-pharma-acquires-global-rights-to-arcoral-tab-from-arcoral-pharma-130416-4863342/ 2016-04-13T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/oncternal-therapeutics-secures-worldwide-license-to-ror1-antibody-from-uc-san-diego-130416-4863351/ 2016-04-13T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/synthon-secures-approval-for-glatiramer-acetate-20-mgml-in-europe-130416-4863357/ 2016-04-13T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-mercks-keytruda-for-head-and-neck-cancer-140416-4863867/ 2016-04-14T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-votes-against-accelerated-approval-of-clovis-rociletinib-lung-cancer-drug-140416-4864252/ 2016-04-14T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/karos-advances-development-of-kar5585-into-clinic-to-treat-pulmonary-arterial-hypertension-140416-4864472/ 2016-04-14T05:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aires-pharmaceuticals-inks-deal-with-duke-university-for-phase-2-study-of-air001-in-hfpef-patients-140416-4864483/ 2016-04-14T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-completes-ccp-08-pivotal-single-dose-comparative-bioavailability-study-140416-4864494/ 2016-04-14T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/kala-pharmaceuticals-raises-68m-funding-to-advance-eyedrop-treatment-140416-4864553/ 2016-04-14T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/pds-biotechnology-reports-positive-phase-1-study-results-for-pds0101-immunotherapy-for-hpv-related-cancers-140416-4864567/ 2016-04-14T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-bristol-myers-opdivo-for-classical-hodgkin-lymphoma-150416-4865420/ 2016-04-15T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ampliphi-biosciences-ends-exclusive-channel-collaboration-with-intrexon-150416-4865654/ 2016-04-15T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/cydan-development-launches-second-orphan-drug-company-150416-4865858/ 2016-04-15T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/psioxus-parker-institute-for-cancer-immunotherapy-plan-to-partner-on-tumor-specific-immuno-gene-therapy-150416-4865890/ 2016-04-15T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/presage-biosciences-extends-research-collaboration-with-takeda-to-discover-novel-cancer-drug-combinations-150416-4865905/ 2016-04-15T05:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/glaxosmithkline-selects-tierpoint-to-support-global-data-consolidation-and-protection-initiatives-150416-4865911/ 2016-04-15T05:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/shire-submits-nda-to-fda-for-new-formulation-of-vyvanse-cii-as-chewable-tablets-150416-4865916/ 2016-04-15T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/halo-pharmaceutical-exxpharma-partner-to-develop-products-using-twin-screw-extrusion-technology-150416-4866257/ 2016-04-15T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/zepatier-showed-superiority-compared-to-sofosbuvir-plus-peginterferon-and-ribavirin-treatment-regimen-in-phase-3-trial-150416-4866260/ 2016-04-15T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/transplant-genomics-quark-pharmaceuticals-form-discovery-and-development-collaboration-150416-4866268/ 2016-04-15T08:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/akari-therapeutics-xl-protein-sign-license-deal-to-develop-long-acting-version-of-coversin-150416-4866282/ 2016-04-15T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-boehringer-ingelheims-gilotrif-for-squamous-cell-lung-cancer-180416-4866720/ 2016-04-18T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-ptc-therapeutics-translarna-for-duchenne-muscular-dystrophy-180416-4866906/ 2016-04-18T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/who-expert-panel-recommends-use-of-sanofi-pasteurs-dengue-vaccine-in-endemic-countries-180416-4867009/ 2016-04-18T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-marinus-ganaxolone-iv-to-treat-status-epilepticus-180416-4867027/ 2016-04-18T04:59:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/newlink-genetics-secures-28m-award-from-dtra-to-develop-multivalent-filovirus-vaccine-4867037/ 2016-04-18T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-unveils-results-from-two-phase-3-studies-evaluating-tenofovir-alafenamide-for-chronic-hbv-infection-180416-4867048/ 2016-04-18T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-apptec-acquires-crelux-to-improve-structure-based-drug-discovery-capabilities-180416-4867062/ 2016-04-18T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-gets-fda-breakthrough-status-for-classical-hodgkin-lymphoma-190416-4867938/ 2016-04-19T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-finds-no-finds-no-deficiency-with-heron-therapeutics-sustol-nda-190416-4868243/ 2016-04-19T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/heptares-kymab-partner-to-develop-novel-antibody-therapeutics-190416-4868306/ 2016-04-19T05:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/enumeral-pieris-pharmaceuticals-sign-license-and-transfer-agreement-190416-4868324/ 2016-04-19T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/sunny-pharmtech-and-vitruvias-partner-to-co-develop-several-high-value-generic-drugs-190416-4868338/ 2016-04-19T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/compugen-achieves-preclinical-milestone-in-cancer-immunotherapy-collaboration-with-bayer-190416-4868348/ 2016-04-19T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoantibiotics-acquires-biotechnology-firm-lat-pharma-190416-4868353/ 2016-04-19T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-says-phase-3-trial-data-supports-efficacy-of-ibrance-breast-cancer-drug-200416-4869246/ 2016-04-20T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/astex-genentech-partner-to-explore-combination-treatment-for-acute-myeloid-leukemia-200416-4869642/ 2016-04-20T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dalcor-completes-150m-financing-to-continue-development-of-dalcetrapib-in-acs-200416-4869693/ 2016-04-20T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-opens-respiratory-manufacturing-facility-in-ware-uk-200416-4869701/ 2016-04-20T05:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tigenix-selects-tfs-for-first-clinical-trial-to-treat-severe-sepsis-with-allogeneic-expanded-adipose-derived-stem-cells-200416-4869712/ 2016-04-20T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-launches-dyanavel-xr-oral-suspension-cii-to-treat-children-with-adhd-200416-4869724/ 2016-04-20T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-pierre-fabre-sign-multi-year-compound-management-deal-200416-4869738/ 2016-04-20T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-afinitor-drug-reduces-seizures-in-tuberous-sclerosis-complex-patients-210416-4870540/ 2016-04-21T01:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/basilea-signs-deal-with-barda-for-phase-3-development-of-ceftobiprole-antibiotic-210416-4871026/ 2016-04-21T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-removes-clinical-hold-cara-therapeutics-postoperative-pain-trial-for-iv-cr845-210416-4871081/ 2016-04-21T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/oncbiomune-signs-deal-with-vitel-to-form-jv-to-develop-cancer-therapies-210416-4871099/ 2016-04-21T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/second-genome-secures-426m-funding-to-expand-microbiome-discovery-platform-210416-4871114/ 2016-04-21T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/yabao-pharmaceutical-salus-pharma-partner-to-develop-generic-drugs-210416-4871127/ 2016-04-21T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sbp-gsk-create-new-center-for-translational-neuroscience-210416-4871138/ 2016-04-21T06:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bristol-myers-squibb-selects-medidata-clinical-cloud-to-help-manage-clinical-trials-210416-4871496/ 2016-04-21T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-forms-two-oncology-focused-collaborations-with-cytomx-and-argenx-220416-4871813/ 2016-04-22T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-cannabis-drug-gets-fda-orphan-drug-status-220416-4872358/ 2016-04-22T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/tapimmune-to-start-phase-2-ovarian-cancer-trial-with-astrazenecas-durvalumab-220416-4872442/ 2016-04-22T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/immune-therapeutics-signs-binding-loi-to-acquire-chinese-car-t-technology-and-clinical-data-220416-4872461/ 2016-04-22T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/helixs-trial-steering-committee-recommends-to-start-phase-ii-l-dos47-study-in-nsclc-220416-4872476/ 2016-04-22T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fibrocell-announces-last-patient-visit-for-primary-endpoint-analysis-in-phase-ii-trial-of-azficel-t-to-treat-vocal-cord-scarring-220416-4872492/ 2016-04-22T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/aptuit-acquires-exquiron-biotech-220416-4872513/ 2016-04-22T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/biomarin-enrolls-first-patient-in-phase-12-trial-of-naglu-fusion-protein-bmn-250-to-treat-mps-iiib-220416-4872732/ 2016-04-22T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-reports-20-week-results-from-fitzroy-study-with-jak1-inhibitor-filgotinib-in-crohns-disease-220416-4872736/ 2016-04-22T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-launches-genomics-initiative-to-transform-drug-discovery-and-development-250416-4873134/ 2016-04-25T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-lundbecks-resubmitted-application-for-iv-form-of-anti-epileptic-drug-carbamazepine-250416-4873656/ 2016-04-25T05:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bioasis-technologies-signs-license-deal-with-astellas-research-institute-of-america-250416-4873671/ 2016-04-25T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/hvivo-seek-to-work-together-to-develop-vaccines-against-flu-and-zika-infections-250416-4873738/ 2016-04-25T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/chinese-patent-office-plans-to-grant-patent-relating-to-immunicums-cancer-immune-primer-intuvax-250416-4873756/ 2016-04-25T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-opdivo-wins-fda-breakthrough-designation-for-head-and-neck-cancer-260416-4874594/ 2016-04-26T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-breaks-ground-on-200m-waco-facility-expansion-in-texas-260416-4874918/ 2016-04-26T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-secures-eu-approval-for-new-hiv-treatment-260416-4874976/ 2016-04-26T06:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aytu-bioscience-buys-us-commercial-rights-to-natesto-nasal-gel-260416-4874986/ 2016-04-26T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/worldwide-clinical-trials-opens-new-site-in-st-petersburg-russia-260416-4874998/ 2016-04-26T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmx-completes-enrollment-in-phase-2a-study-of-bpx-01-topical-antibiotic-for-acne-260416-4875008/ 2016-04-26T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-abbvies-snda-for-viekira-pak-without-rbv-in-genotype-1b-chronic-hepatitis-c-patients-260416-4875018/ 2016-04-26T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-sells-us-rights-to-gout-drug-zurampic-to-ironwood-pharmaceuticals-260416-4875319/ 2016-04-27T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-wins-216m-contract-option-from-barda-for-ebola-vaccine-development-270416-4875715/ 2016-04-27T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-votes-against-approval-of-sareptas-duchenne-muscular-dystrophy-drug-270416-4875734/ 2016-04-27T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-completes-patient-enrollment-in-bococizumab-spire-2-cardiovascular-outcome-trial-270416-4875777/ 2016-04-27T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-pharmaceuticals-xtampza-er-opioid-painkiller-wins-fda-approval-270416-4876346/ 2016-04-27T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/arch-biopartners-ab569-receives-positive-opinion-from-ema-comp-270416-4876397/ 2016-04-27T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-gsk-enter-second-collaboration-to-develop-bi-specific-antibodies-270416-4876413/ 2016-04-27T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-ilaris-wins-three-fda-breakthrough-designations-to-treat-periodic-fever-syndromes-280416-4877121/ 2016-04-28T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-starts-phase-12-study-of-glembatumumab-vedotin-in-squamous-cell-lung-cancer-280416-4877248/ 2016-04-28T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ocular-completes-end-of-phase-2-review-with-fda-for-otx-tp-for-glaucoma-and-ocular-hypertension-280416-4877271/ 2016-04-28T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ibc-generium-selects-goodwin-biotechnology-to-optimize-process-of-igg-based-bispecific-antibody-280416-4877295/ 2016-04-28T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-achieves-milestone-in-drug-discovery-collaboration-with-alexion-pharmaceuticals-280416-4877313/ 2016-04-28T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-pharmaceuticals-unveils-new-program-to-develop-vasculan-for-systemic-sclerosis-280416-4877506/ 2016-04-28T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-marketing-authorisation-to-lonsurf-in-mcrc-280416-4877871/ 2016-04-28T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-offers-to-buy-medivation-for-93bn-290416-4878772/ 2016-04-29T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/neovacs-wins-fda-approval-to-extend-phase-iib-clinical-trial-in-lupus-to-us-290416-4879245/ 2016-04-29T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-agrees-to-buy-stemcentrx-for-58bn-290416-4879322/ 2016-04-29T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/therabron-therapeutics-wins-fda-fast-track-designation-for-rhcc10-290416-4879330/ 2016-04-29T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-breaks-ground-on-new-manufacturing-facility-in-norton-massachusetts-290416-4879340/ 2016-04-29T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-plans-to-start-second-clinical-trial-of-alks-7119-290416-4879353/ 2016-04-29T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/theratechnologies-unveils-completion-of-enrollment-for-phase-iii-ibalizumab-trial-290416-4879362/ 2016-04-29T06:34:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bioq-pharma-expands-us-license-and-supply-deal-with-sandoz-290416-4879589/ 2016-04-29T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-acadias-nuplazid-to-treat-parkinsons-disease-psychosis-020516-4879858/ 2016-05-02T01:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/european-chmp-adopts-positive-opinion-for-afinitor-to-treat-select-gi-and-lung-neuroendocrine-tumors-020516-4880406/ 2016-05-02T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-receives-positive-chmp-opinion-for-odefsey-to-treat-hiv-020516-4880457/ 2016-05-02T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/heritage-pharmaceuticals-issues-product-safety-warning-counterfeit-drug-product-bicnu-020516-4880473/ 2016-05-02T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-unveils-positive-data-from-multiple-dose-phase-1-trial-of-ctp-656-020516-4880492/ 2016-05-02T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-announces-milestone-in-drug-discovery-collaboration-with-novartis-020516-4880510/ 2016-05-02T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/business-review-is-looking-for-a-new-online-reporter-030516-4881664/ 2016-05-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-formulation-of-eisais-fycompa-to-treat-seizure-disorders-030516-4881299/ 2016-05-03T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-find-new-treatment-for-lethal-resistant-prostate-cancers-030516-4881709/ 2016-05-03T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/graybug-vision-secures-445m-funding-for-clinical-development-activities-030516-4881776/ 2016-05-03T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-vanc-pharmaceuticals-cortivera-h-product-for-minor-skin-irritations-030516-4881791/ 2016-05-03T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-receives-final-fda-approval-for-generic-version-of-valeants-benzaclin-pump-topical-gel-030516-4881803/ 2016-05-03T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/seres-achieves-target-enrollment-of-ser-109-phase-2-study-to-prevent-recurrent-clostridium-difficile-infection-030516-4881815/ 2016-05-03T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-serono-expands-biopharmaceutical-rd-facility-in-billerica-massachusetts-030516-4881833/ 2016-05-03T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/protalex-receives-positive-interim-review-in-european-phase-1b-study-of-prtx-100-to-treat-immune-thrombocytopenia-030516-4882108/ 2016-05-03T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/veristat-acquires-uk-based-cro-spero-oncology-030516-4882138/ 2016-05-03T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/kastle-therapeutics-to-acquire-rights-of-kynamro-from-ionis-pharmaceuticals-040516-4882864/ 2016-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-appeal-55m-compensation-awarded-in-talcum-powder-case-4883166/ 2016-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-looks-to-spin-off-hemophilia-business-to-focus-on-neurology-medicines-4882799/ 2016-05-04T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/foamix-announces-completion-of-enrollment-in-phase-ii-clinical-trial-of-minocycline-foam-to-treat-papulopustular-rosacea-040516-4882934/ 2016-05-04T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-launches-first-clinical-trial-in-multiple-sclerosis-for-tg-1101-040516-4882938/ 2016-05-04T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/ionis-pharmaceuticals-and-kastle-therapeutics-announce-acquisition-of-kynamro-040516-4882954/ 2016-05-04T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mount-sinai-galmed-collaborate-for-phase-iia-trial-to-evaluate-effect-of-aramchol-in-combination-with-vitamin-d-to-treat-patients-with-fibrotic-nonalcoholic-fatty-liver-disease-040516-4882978/ 2016-05-04T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/celtaxsys-begins-eu-enrollment-for-cf-lung-function-preservation-trial-of-acebilustat-anti-inflammatory-therapy-for-cystic-fibrosis-040516-4882983/ 2016-05-04T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-eli-lillys-olaratumab-to-treat-soft-tissue-sarcoma-050516-4883926/ 2016-05-05T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ergomed-to-acquire-haemostatix-050516-4884414/ 2016-05-05T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bayers-stivarga-increases-overall-survival-in-liver-cancer-patients-050516-4884496/ 2016-05-05T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharmaceuticals-unveils-ctp-543-to-treat-alopecia-areata-050516-4884506/ 2016-05-05T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-expand-carlsbad-viral-and-gene-therapy-plant-in-california-050516-4884516/ 2016-05-05T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/sirnaomics-raises-10m-to-fund-clinical-development-of-anti-fibrosis-programs-050516-4884522/ 2016-05-05T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-unveils-top-line-results-of-phase-iib-trial-with-elsiglutide-to-prevent-chemotherapy-induced-diarrhea-in-colorectal-cancer-patients-050516-4884535/ 2016-05-05T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/amri-to-buy-italian-api-maker-euticals-for-358m-060516-4885413/ 2016-05-06T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-therapeutics-forms-accurins-development-collaboration-with-affilogic-060516-4885767/ 2016-05-06T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/allenas-investigational-therapy-wins-fda-orphan-drug-status-to-treat-pediatric-hyperoxaluria-060516-4885794/ 2016-05-06T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiome-allergan-sign-xydalba-licensing-deal-in-international-markets-060516-4885805/ 2016-05-06T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-completes-target-enrollment-of-phase-3-trial-of-actimmune-to-treat-friedreichs-ataxia-060516-4885816/ 2016-05-06T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-version-of-apresoline-injection-in-us-060516-4885824/ 2016-05-06T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-launches-dpx-neo-program-to-develop-patient-specific-neoepitope-immunotherapies-060516-4885836/ 2016-05-06T06:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/alder-licenses-clazakizumab-inflammation-candidate-rights-to-vitaeris-090516-4886587/ 2016-05-09T02:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/immunocellular-wins-regulatory-approval-to-start-ict-107-phase-3-trial-in-newly-diagnosed-glioblastoma-090516-4887048/ 2016-05-09T06:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biosortia-pharmaceuticals-launches-three-new-oncology-research-projects-090516-4887079/ 2016-05-09T06:20:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/valeant-pharmaceuticals-forms-committee-to-oversee-pricing-of-drugs-090516-4887083/ 2016-05-09T06:23:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/akili-interactive-labs-opens-enrollment-for-stars-adhd-trial-090516-4887099/ 2016-05-09T06:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tolmar-wins-fda-approval-for-eligard-to-treat-advanced-prostate-cancer-090516-4887107/ 2016-05-09T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/act-genomics-raises-125m-in-series-b-funding-090516-4887119/ 2016-05-09T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-imbruvica-label-to-include-survival-data-100516-4887769/ 2016-05-10T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-pharmaceuticals-agrees-to-sell-european-operations-to-incyte-100516-4888048/ 2016-05-10T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-pharmaceutical-establishes-taiho-ventures-to-support-oncology-biotech-start-ups-110516-4889612/ 2016-05-10T05:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gates-foundation-gives-38m-grant-to-takeda-for-polio-eradication-100516-4888295/ 2016-05-10T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/wave-life-sciences-to-advance-next-generation-nucleic-acid-therapies-for-duchenne-muscular-dystrophy-100516-4888311/ 2016-05-10T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-launches-50mg-and-150mg-fenofibrate-capsules-in-ani-label-100516-4888324/ 2016-05-10T05:44:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mgb-biopharma-holds-pre-ind-meeting-with-fda-on-mgb-bp-3-development-program-100516-4888336/ 2016-05-10T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/x4-pharmaceuticals-starts-phase-12-study-of-x4p-001-in-advanced-clear-cell-renal-cell-carcinoma-100516-4888352/ 2016-05-10T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/dermiras-facial-acne-vulgaris-study-of-drm01-shows-improvement-in-all-endpoints-110516-4889132/ 2016-05-11T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/aptinyx-raises-65m-for-neurological-disorder-drugs-110516-4889368/ 2016-05-11T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/paratek-receives-favorable-feedback-from-fda-for-design-of-omadacycline-oral-only-skin-infection-phase-3-study-110516-4889598/ 2016-05-11T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-bioscience-establishes-egfr-mutated-non-small-cell-lung-cancer-models-110516-4889633/ 2016-05-11T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/first-dosing-of-pfizer-dart-candidate-in-phase-1-trial-triggers-2m-milestone-payment-to-macrogenics-110516-4889650/ 2016-05-11T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/jhl-biotech-opens-biosimilars-manufacturing-plant-in-china-110516-4889671/ 2016-05-11T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/nls-pharma-submits-ind-to-fda-for-mazindol-to-treat-adhd-120516-4893180/ 2016-05-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ucla-scientists-use-gene-editing-technology-for-faster-antiviral-drug-development-120516-4893200/ 2016-05-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-bristol-myers-squibbs-two-new-oncology-treatments-120516-4890696/ 2016-05-12T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ibm-research-and-singapores-bioengineering-institute-develop-anti-viral-technology-120516-4891264/ 2016-05-12T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-completes-enrollment-for-phase-2-trial-of-gr-md-02-in-fibrosis-patients-120516-4891301/ 2016-05-12T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-h3-biomedicines-ind-application-to-start-phase-1-trials-for-oncology-drug-candidate-h3b-8800-120516-4891308/ 2016-05-12T05:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biodelivery-sciences-grants-exclusive-rights-to-develop-onsolis-in-us-to-collegium-120516-4891319/ 2016-05-12T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/g1-therapeutics-secures-47m-series-c-financing-120516-4891326/ 2016-05-12T06:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sunshine-biopharma-signs-licensing-deal-for-anastrozole-drug-to-treat-breast-cancer-120518-4891345/ 2016-05-12T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-selumetinib-gets-fda-orphan-drug-status-for-thyroid-cancer-120516-4891640/ 2016-05-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/neovacs-stellar-biotechnologies-sign-jv-deal-to-make-conjugated-therapeutic-vaccines-130516-4892732/ 2016-05-13T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-halts-riociguat-mid-stage-study-over-safety-concerns-130516-4892786/ 2016-05-13T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/caladrius-biosciences-secures-fda-orphan-drug-designation-for-clbs03-to-treat-type-1-diabetes-130516-4892801/ 2016-05-13T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/innocrin-starts-4892814/ 2016-05-13T06:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/seres-therapeutics-forms-research-collaboration-with-memorial-sloan-kettering-cancer-center-130516-4892822/ 2016-05-13T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-settles-pennsaid-diclofenac-sodium-topical-solution-2-ww-patent-litigation-with-teligent-4892836/ 2016-05-13T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/tetraphase-pharmaceuticals-offers-update-on-eravacycline-regulatory-and-development-status-130516-4893141/ 2016-05-13T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/htg-molecular-diagnostics-signs-immuno-oncology-research-collaboration-deal-with-bristol-myers-squibb-130516-4893147/ 2016-05-13T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/aegerion-reaches-preliminary-agreements-in-principle-with-doj-and-sec-over-ongoing-investigations-130516-4893161/ 2016-05-13T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/five-prime-advances-fpa008-into-phase-2-dose-expansion-in-pvns-patients-130516-4893171/ 2016-05-13T08:35:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-to-buy-renaissances-dermatology-business-in-1bn-deal-160516-4893625/ 2016-05-16T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/us-cdc-unveils-funds-to-fight-zika-locally-160516-4894177/ 2016-05-16T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-blocks-drugs-from-use-in-lethal-injections-160516-4894255/ 2016-05-16T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-doses-first-patient-in-phase-1-trial-of-dcr-ph1-in-patients-with-primary-hyperoxaluria-type-1-160516-4894275/ 2016-05-16T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-edge-therapeutics-eg-1962-to-treat-subarachnoid-hemorrhage-160516-4894286/ 2016-05-16T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-alprolix-treat-haemophilia-b-160615-4894297/ 2016-05-16T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eisais-lenvima-to-treat-advanced-renal-cell-carcinoma-in-combination-with-everolimus-160516-4894308/ 2016-05-16T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/neuromax-completes-enrollment-in-phase-2b-trial-of-bnv-222-in-diabetic-peripheral-neuropathy-160516-4894322/ 2016-05-16T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-buy-anacor-pharmaceuticals-in-52bn-deal-170516-4895022/ 2016-05-17T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/trevenas-trv027-heart-failure-candidate-fails-to-meet-primary-secondary-endpoints-in-phase-2-trial-170516-4895524/ 2016-05-17T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ahf-urges-congress-to-authorize-funding-for-zika-virus-170516-4895604/ 2016-05-17T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/nivalis-therapeutics-doses-first-patient-in-second-phase-2-study-of-n91115-to-treat-cystic-fibrosis-170516-4895612/ 2016-05-17T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-genzyme-forms-multiple-sclerosis-research-collaboration-with-johns-hopkins-school-of-medicine-170516-4895622/ 2016-05-17T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-collaborates-with-university-of-pennsylvania-on-multiple-gene-therapy-programs-4895638/ 2016-05-17T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/neos-therapeutics-launches-adzenys-xr-odt-in-us-to-treat-adhd-in-patients-six-years-and-older-170516-4895852/ 2016-05-17T08:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mckesson-and-walmart-sign-sourcing-deal-for-generic-pharmaceuticals-170516-4895866/ 2016-05-17T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-benralizumab-achieves-primary-endpoint-in-two-phase-3-asthma-trials-180516-4896345/ 2016-05-18T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-squibbs-opdivo-for-classical-hodgkin-lymphoma-180516-4896897/ 2016-05-18T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-celgene-agree-to-establish-metabolic-immuno-oncology-alliance-180516-4896962/ 2016-05-18T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-pharmaceuticals-announces-30-reduction-in-workforce-180516-4896974/ 2016-05-18T06:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bayer-ers-genomics-sign-licensing-deal-for-genome-editing-patents-180516-4896986/ 2016-05-18T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorization-for-actelions-uptravi-to-treat-pulmonary-arterial-hypertension-180516-4896994/ 2016-05-18T06:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-genmabs-sbla-for-ofatumumab-in-combination-with-fludarabine-and-cyclophosphamide-in-relapsed-cll-180516-4897247/ 2016-05-18T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mitochon-pharmaceuticals-raises-16m-for-clinical-stage-development-180516-4897251/ 2016-05-18T08:29:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-researchers-discover-gene-variation-that-lowers-heart-attack-risk-190516-4897649/ 2016-05-19T02:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/macrogenics-janssen-partner-to-develop-new-dart-molecule-for-cancer-treatment-190516-4898035/ 2016-05-19T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genentechs-atezolizumab-for-advanced-urothelial-carcinoma-190516-4898135/ 2016-05-19T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/eag-unveils-further-investments-to-improve-abc-laboratories-biopharmaceutical-characterization-capabilities-190516-4898146/ 2016-05-19T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/rdd-pharma-doses-first-patient-in-phase-3-trial-for-chronic-anal-fissure-190516-4898158/ 2016-05-19T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/synthon-starts-second-part-of-phase-i-trial-with-anti-her2-antibody-drug-conjugate-syd985-190516-4898173/ 2016-05-19T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/martindale-pharma-announces-expansion-of-european-commercial-activities-190516-4898440/ 2016-05-19T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-stops-lee011-trial-due-to-positive-efficacy-in-hrher2-advanced-breast-cancer-190516-4898453/ 2016-05-19T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-expands-devens-biologics-facility-in-massachusetts-190516-4898467/ 2016-05-19T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/jhl-biotech-selects-paizabio-to-provide-fill-finish-services-for-multiple-projects-190516-4898480/ 2016-05-19T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-nice-rejects-roches-perjeta-breast-cancer-drug-200516-4901030/ 2016-05-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/us-senate-approves-11bn-emergency-fund-to-combat-zika-virus-200516-4899267/ 2016-05-20T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-and-baxalta-announce-initiation-of-phase-i-study-of-mm-151-in-combination-with-onivyde-regimen-in-metastatic-colorectal-cancer-200516-4899414/ 2016-05-20T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/celator-pharmaceuticals-announces-vyxeos-granted-breakthrough-therapy-designation-200516-4899425/ 2016-05-20T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/evoke-enters-exclusive-commercial-supply-agreement-for-active-pharmaceutical-ingredient-in-evk-001-200516-4899436/ 2016-05-20T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/inovalon-announces-agreement-with-bristol-myers-squibb-to-focus-on-real-world-outcomes-and-value-based-contracting-initiatives-200516-4899452/ 2016-05-20T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-starts-fortihfy-clinical-program-to-study-heart-failure-200516-4899649/ 2016-05-20T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/european-regulator-accepts-pfizers-trumenba-marketing-authorization-application-for-review-230516-4900198/ 2016-05-23T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-to-stop-plumiaz-development-to-treat-epilepsy-seizure-clusters-230516-4900623/ 2016-05-23T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/avalon-ventures-coi-form-pdi-therapeutics-to-develop-novel-immune-oncology-therapies-230516-4900713/ 2016-05-23T05:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biopharma-services-wins-20m-contract-from-fdas-center-for-drug-evaluation-and-research-230516-4900731/ 2016-05-23T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-anavex-2-73-to-treat-rett-syndrome-230516-4900745/ 2016-05-23T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/santalis-enrolls-first-patient-in-phase-2-trial-of-east-indian-sandalwood-oil-to-treat-mild-to-moderate-plaque-psoriasis-230516-4900757/ 2016-05-23T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/colucid-pharmaceuticals-starts-second-phase-3-trial-of-lasmiditan-in-migraine-230516-4900773/ 2016-05-23T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-darzalex-for-multiple-myeloma-240516-4901495/ 2016-05-24T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-biomed-x-start-project-to-identify-new-treatment-approaches-for-psychiatric-diseases-240516-4902103/ 2016-05-24T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-accepts-sandoz-biosimilar-rituximab-regulatory-submission-240516-4902132/ 2016-05-24T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/vtesse-completes-dose-finding-part-of-phase-2b3-trial-for-vts-270-to-treat-niemann-pick-type-c1-disease-240516-4902143/ 2016-05-24T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-unveils-positive-results-from-phase-2-trial-of-cabozantinib-in-previously-untreated-advanced-rcc-240516-4902159/ 2016-05-24T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/zambon-launches-xadago-in-uk-for-patients-with-mid-to-late-stage-parkinsons-disease-240516-4902170/ 2016-05-24T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-review-samsung-bioepis-bla-for-biosimilar-of-remicade-240516-4902201/ 2016-05-24T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/isofol-announces-successful-meetings-with-european-and-us-regulatory-authorities-on-design-of-phase-ii-trial-of-modufolin-250516-4907637/ 2016-05-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-indication-for-janssen-pharmaceuticals-invokamet-diabetes-drug-250516-4902924/ 2016-05-25T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutixs-phase-2-trial-of-prurisol-to-treat-mild-to-moderate-psoriasis-meets-primary-endpoint-250516-4903426/ 2016-05-25T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-relvar-ellipta-succeeds-in-salford-lung-study-250516-4903532/ 2016-05-25T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-says-it-has-potential-to-launch-20-new-products-in-10-years-250516-4903545/ 2016-05-25T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-approval-of-novo-nordisks-ideglira-diabetes-drug-250516-4903560/ 2016-05-25T05:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pdl-biopharma-commits-to-equity-investment-in-noden-pharma-250516-4903569/ 2016-05-25T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-reaches-pre-clinical-proof-of-concept-stage-with-oncology-lead-250516-4903578/ 2016-05-25T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-releases-largest-ever-study-on-clinical-development-success-rates-260516-4907614/ 2016-05-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-starts-phase-1-trial-of-immuno-oncology-drug-candidate-alks-4230-260516-4904430/ 2016-05-26T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-backs-approval-of-sanofi-treatment-for-adults-with-type-2-diabetes-260516-4904812/ 2016-05-26T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-3-trial-of-vadastuximab-talirine-for-newly-diagnosed-aml-patients-260516-4904874/ 2016-05-26T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/baxalta-unveils-positive-phase-1-results-for-bax-930-investigational-recombinant-adamts13-to-treat-http-260516-4904882/ 2016-05-26T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/allied-bristol-life-sciences-completes-abls-ii-drug-candidate-feasibility-programme-260516-4904893/ 2016-05-26T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/serial-biopharma-entrepreneurial-team-launches-drug-development-firm-arrivo-bioventures-260516-4904906/ 2016-05-26T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-laboratories-acquires-six-otc-brands-260516-4904915/ 2016-05-26T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/dow-corning-to-present-webinar-on-effective-silicone-based-topical-formulations-260516-4905255/ 2016-05-26T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/indivior-secures-fda-fast-track-designation-for-rbp-6000-buprenorphine-monthly-depot-to-treat-opioid-use-disorder-270516-4907600/ 2016-05-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-oncology-doses-first-patient-in-phase-3-tivo-3-study-of-tivozanib-in-renal-cell-carcinoma-270516-4907608/ 2016-05-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roches-phase-iii-study-of-gazyva-meets-primary-endpoint-early-270516-4905624/ 2016-05-27T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-csl-behrings-single-chain-afstyla-for-hemophilia-a-270516-4906008/ 2016-05-27T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/symbiomix-reports-positive-results-for-sym-1219-in-bacterial-vaginosis-270516-4906071/ 2016-05-27T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/integral-molecular-develops-b-cell-cloning-technology-to-discover-rare-antibodies-against-membrane-proteins-270615-4906087/ 2016-05-27T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/titan-pharmaceuticals-wins-fda-approval-for-probuphine-to-treat-opioid-dependence-270516-4906098/ 2016-05-27T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-zinbryta-to-treat-relapsing-forms-of-multiple-sclerosis-300516-4906783/ 2016-05-30T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-faslodex-meets-primary-endpoint-in-breast-cancer-trial-300516-4907015/ 2016-05-30T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-strimvelis-to-treat-immune-deficiency-disorder-in-children-300516-4907116/ 2016-05-30T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-gets-positive-chmp-opinion-in-europe-for-revestive-for-paediatric-patients-with-sbs-300516-4907138/ 2016-05-30T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/kitov-announces-completion-of-manufacturing-pivotal-batches-of-kit-302-for-registration-in-us-300516-4907151/ 2016-05-30T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-backs-extended-approval-of-takeda-pharmaceuticals-adcetris-300516-4907167/ 2016-05-30T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-enters-into-global-collaboration-to-develop-jubilants-novel-bet-inhibitor-program-200516-4907188/ 2016-05-30T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-samsung-bioepis-remicade-biosimilar-310516-4908090/ 2016-05-31T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/abivax-starts-second-phase-iia-trial-of-abx464-in-hivaids-patients-310516-4908459/ 2016-05-31T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-to-receive-30m-milestone-payment-from-janssen-in-darzalex-collaboration-310516-4908510/ 2016-05-31T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/european-chmp-adopts-positive-opinion-for-gileads-epclusa-to-treat-all-genotypes-of-chronic-hepatitis-c-310516-4908536/ 2016-05-31T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-receives-positive-chmp-opinion-to-extend-indication-of-kyprolis-to-treat-relapsed-multiple-myeloma-310516-4908548/ 2016-05-31T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/jazz-pharmaceuticals-agrees-to-acquire-celator-for-15bn-310516-4908968/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-imbruvica-for-first-line-treatment-of-cll-patients-310516-4908991/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-receives-crl-from-fda-in-response-to-sd-809-nda-310516-4909005/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-receives-positive-chmp-opinion-for-tysabri-use-in-highly-active-rrms-patients-with-inadequate-response-to-prior-ms-therapy-310516-4909007/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-starts-phase-12-trial-of-ap32788-in-patients-with-non-small-cell-lung-cancer-310516-4909009/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chemdiv-signs-drug-discovery-collaboration-deal-with-cystic-fibrosis-foundation-therapeutics-310516-4909011/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-allergans-teflaro-for-pediatric-patients-31-0516-4909013/ 2016-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/kalytera-therapeutics-licenses-transdermal-drug-delivery-technology-from-delivra-020616-4913053/ 2016-06-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-afinitor-drug-secures-eu-approval-for-gi-lung-neuroendocrine-tumors-020616-4910882/ 2016-06-02T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-completes-enrollment-in-all-three-phase-3-studies-of-revefenacin-to-treat-copd-020616-4911455/ 2016-06-02T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-alexions-alxn1210-to-treat-paroxysmal-nocturnal-hemoglobinuria-020616-4911530/ 2016-06-02T06:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/lipidor-cadila-sign-deal-on-joint-commercialization-of-topical-psoriasis-product-020616-4911555/ 2016-06-02T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-granted-access-to-prime-regulatory-support-for-kte-c19-to-treat-chemorefractory-dlbcl-020616-4911568/ 2016-06-02T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-first-generic-of-doxycycline-hyclate-dr-tablets-50-mg-in-us-020616-4911589/ 2016-06-02T06:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-agrees-to-sell-zurampics-european-latin-american-rights-to-grunenthal-030616-4912119/ 2016-06-03T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-starts-eluxa-trial-program-to-further-investigate-olmutinib-lung-cancer-compound-030616-4912680/ 2016-06-03T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-cell-design-labs-collaborate-on-new-car-t-cell-immunotherapies-030616-4912740/ 2016-06-03T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-escends-es-3000-to-treat-chronic-myeloid-leukemia-030616-4912751/ 2016-06-03T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/innovus-to-request-regulatory-guidance-for-fluticare-product-filing-in-europe-to-treat-allergic-rhinitis-030616-4912770/ 2016-06-03T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-completes-sale-of-european-operations-and-out-license-of-european-rights-to-iclusig-030616-4912785/ 2016-06-03T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-announces-preclinical-collaboration-for-depovax-based-malaria-vaccine-030616-4912801/ 2016-06-03T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-medivation-start-phase-iii-trial-of-enzalutamide-to-treat-triple-negative-breast-cancer-030616-4912993/ 2016-06-03T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/virtual-reality-smartphone-app-provides-glimpse-into-life-with-dementia-030616-4913004/ 2016-06-03T07:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/genisphere-signs-collaborative-research-option-to-license-deal-with-medimmune-030616-4913048/ 2016-06-03T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/promis-neurosciences-identifies-multiple-product-candidates-targeting-alzheimers-disease-030616-4913054/ 2016-06-03T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-expands-gmp-manufacturing-capacity-in-europe-030616-4913060/ 2016-06-03T08:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-debio-1143-to-treat-ovarian-cancer-030616-4913066/ 2016-06-03T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-completes-32bn-acquisition-of-baxalta-060616-4913401/ 2016-06-06T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-pierre-fabre-and-merck-start-phase-3-beacon-crc-trial-060616-4914042/ 2016-06-06T06:20:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/roches-tecentriq-cancer-immunotherapy-improves-overall-survival-in-phase-ii-study-060616-4914119/ 2016-06-06T06:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/viiv-healthcare-signs-public-tender-deal-with-botswana-ministry-of-health-for-dolutegravir-060616-4914143/ 2016-06-06T06:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/daratumumab-combination-therapy-extends-progression-free-survival-in-previously-treated-patients-with-multiple-myeloma-060616-4914158/ 2016-06-06T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-combination-therapy-tafinlar-mekinist-demonstrates-survival-benefit-in-advanced-melanoma-patients-070616-4914952/ 2016-06-07T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/alexions-phase-3-study-of-eculizumab-in-refractory-gmg-fails-to-meet-primary-goal-070616-4915370/ 2016-06-07T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-diosynth-to-collaborate-with-merck-on-new-microbial-biologics-facility-070616-4915392/ 2016-06-07T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/frontida-acquires-sun-pharmaceuticals-philadlelphia-and-aurora-facilities-070616-4915404/ 2016-06-07T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-to-support-moderna-therapeutics-nonclinical-discovery-and-development-efforts-070616-4915412/ 2016-06-07T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/epimab-biotherapeutics-innovent-biologics-establish-multi-target-bispecific-antibody-collaboration-070616-4915421/ 2016-06-07T06:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-warns-otc-antacid-products-containing-aspirin-may-cause-severe-bleeding-070616-4915487/ 2016-06-07T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-xeljanz-meets-primary-endpoints-in-second-phase-3-trial-for-psoriatic-arthritis-080616-4916376/ 2016-06-08T03:34:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-cat-2054-fails-to-meet-primary-endpoint-in-phase-2a-trial-of-hypercholesterolemia-080616-4916761/ 2016-06-08T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-md-anderson-form-research-collaboration-in-immuno-oncology-focused-on-lung-cancer-080616-4916774/ 2016-06-08T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/atossa-genetics-starts-new-drug-development-program-with-oral-endoxifen-080616-4916784/ 2016-06-08T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-innovent-expand-partnership-for-discovery-of-antibodies-and-bispecifics-080616-4916794/ 2016-06-08T06:19:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ec-grants-orphan-medicinal-product-designation-to-agtcs-gene-therapy-to-treat-x-linked-retinitis-pigmentosa-080616-4916807/ 2016-06-08T06:27:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biogen-to-continue-development-of-opicinumab-ms-drug-despite-failure-in-phase-ii-trial-080616-4916873/ 2016-06-08T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/momenta-pharmaceuticals-starts-phase-1-trial-of-m281-anti-fcrn-monoclonal-antibody-090616-4919937/ 2016-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-pfizers-alo-02-extended-release-capsules-for-approval-100616-4919953/ 2016-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pieris-pharmaceuticals-closes-165m-private-placement-090616-4919956/ 2016-06-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sirukumab-meets-both-co-primary-endpoints-in-rheumatoid-arthritis-study-090616-4917514/ 2016-06-09T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-takeda-partner-to-develop-rare-genetic-disease-therapies-090616-4918050/ 2016-06-09T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-phase-2-study-of-erenumab-in-chronic-migraine-meets-primary-endpoint-090616-4918127/ 2016-06-09T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/insmed-withdraws-marketing-authorization-application-for-arikayce-in-europe-090616-4918142/ 2016-06-09T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-remedys-cirara-to-treat-large-hemispheric-infarctions-090616-4918157/ 2016-06-09T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/crispr-gains-license-to-anagenesis-p2mcs-technology-for-cell-therapy-for-muscle-diseases-090616-4918177/ 2016-06-09T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/lion-biotechnologies-closes-100m-private-financing-090616-4918189/ 2016-06-09T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/aspen-to-buy-rights-to-astrazenecas-global-anaesthetics-portfolio-outside-us-100616-4918936/ 2016-06-10T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-agrees-to-buy-afferent-pharmaceuticals-in-12bn-transaction-100616-4919419/ 2016-06-10T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/reneuron-to-tackle-brain-cancer-with-exosome-platform-100616-4919527/ 2016-06-10T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-basilea-start-ma-program-for-isavuconazole-to-treat-patients-with-invasive-fungal-infections-in-europe-100616-4919543/ 2016-06-10T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-to-review-valeants-nda-for-brodalumab-100616-4919556/ 2016-06-10T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-starts-phase-1-trial-for-aln-ttrsc02-rnai-therapeutic-to-treat-ttr-mediated-amyloidosis-100616-4919569/ 2016-06-10T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-snda-for-72-mcg-dose-of-linaclotide-in-chronic-idiopathic-constipation-100616-4919586/ 2016-06-10T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fluoropharma-announces-letter-of-intent-to-buy-ground-fluor-pharmaceuticals-100616-4919921/ 2016-06-10T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-biopharma-reports-positive-results-from-phase-1-trial-of-td-1473-100616-4919927/ 2016-06-10T07:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/reaction-biology-awarded-subcontract-to-help-speed-up-drug-discovery-100616-4919995/ 2016-06-10T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-to-buy-eight-us-drugs-from-teva-and-allergan-for-350m-130616-4920544/ 2016-06-13T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-wins-fda-approval-to-lower-weight-limit-for-dolutegravir-hiv-drug-in-children-and-adolescents-130616-4920889/ 2016-06-13T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-completes-decentralized-procedure-in-europe-for-immunoglobulin-treatment-cuvitru-130616-4920900/ 2016-06-13T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/agios-ag-348-achieves-proof-of-concept-in-phase-2-drive-pk-study-130616-4920907/ 2016-06-13T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/spotlight-innovation-finalizes-plans-to-sign-deal-with-maitland-labs-to-establish-drug-development-facility-130616-4920925/ 2016-06-13T06:14:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/american-diabetes-association-and-ibm-partner-on-diabetes-management-130616-4920939/ 2016-06-13T06:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ertugliflozin-shows-significant-a1c-reductions-in-patients-with-type-2-diabetes-in-two-phase-3-trials-130616-4921021/ 2016-06-13T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-secures-fda-breakthrough-therapy-designation-for-two-rare-gi-drugs-140616-4921825/ 2016-06-14T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-mk-1293-insulin-glargine-meets-primary-endpoint-in-two-phase-3-trials-140616-4922156/ 2016-06-14T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/alpine-immune-sciences-raises-48m-to-develop-next-generation-immunotherapies-140616-4922168/ 2016-06-14T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/genticel-completes-two-milestones-in-preparation-for-phase-3-program-of-gtl001-140616-4922180/ 2016-06-14T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-review-amgens-bla-for-adalimumab-biosimilar-140616-4922195/ 2016-06-14T05:40:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/faron-pharmaceuticals-licenses-traumakine-korean-rights-to-pharmbio-korea-140616-4922204/ 2016-06-14T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/reneuron-completes-patient-recruitment-for-phase-ii-stroke-trial-140616-4922242/ 2016-06-14T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/marathon-pharmaceuticals-submits-deflazacort-nda-to-treat-duchenne-muscular-dystrophy-150616-4923217/ 2016-06-15T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-espero-pharmaceuticals-gonitro-sublingual-powder-for-angina-150616-4923547/ 2016-06-15T05:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/clinigen-signs-global-access-deal-with-galen-for-chemotherapy-drug-daunoxome-150616-4923660/ 2016-06-15T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/twoxar-completes-initial-studies-of-new-rheumatoid-arthritis-drug-candidates-150616-4923676/ 2016-06-15T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/senhwa-biosciences-enrolls-first-patient-in-phase-iii-cx-5461-trial-in-triple-negative-breast-cancer-150616-4923698/ 2016-06-15T06:20:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teva-voluntarily-suspends-marketing-for-zecuity-in-us-150616-4923707/ 2016-06-15T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-nls-pharmas-ind-for-phase-ii-study-of-mazindol-in-adults-with-adhd-160616-4926685/ 2016-06-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/therapix-biosciences-files-application-with-fda-to-approve-orphan-designation-for-thx-rs01-drug-160616-4926745/ 2016-06-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-higher-dosage-strength-orfadin-capsule-for-ht-1-treatment-160616-4924529/ 2016-06-16T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-label-for-emphysema-treatment-glassia-160616-4924959/ 2016-06-16T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmaceutical-firm-allecra-therapeutics-raises-eur22m-funding-160616-4925008/ 2016-06-16T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/peptidream-earns-milestone-for-initiation-of-clinical-development-for-bms-first-collaboration-product-candidate-160616-4925019/ 2016-06-16T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/rgenix-announces-33m-series-b-financing-to-develop-cancer-therapeutics-160616-4925029/ 2016-06-16T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/carbylan-therapeutics-kalvista-pharmaceuticals-enter-into-share-purchase-agreement-160616-4925039/ 2016-06-16T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/flex-pharma-starts-phase-2-efficacy-study-in-multiple-sclerosis-160616-4925052/ 2016-06-16T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-breaks-ground-on-new-200m-biologics-manufacturing-plant-in-massachusetts-170616-4926037/ 2016-06-17T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-beats-out-chemotherapy-in-phase-3-lung-cancer-trial-170616-4926366/ 2016-06-17T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/oncobiologics-phase-3-clinical-plan-for-humira-biosimilar-receives-first-eu-cta-approval-170616-4926418/ 2016-06-17T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-secures-fda-approval-for-generic-version-of-ofirmev-acetaminophen-injection-170616-4926426/ 2016-06-17T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-bioscience-strengthens-global-immuno-oncology-platform-170616-4926431/ 2016-06-17T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/blade-therapeutics-raises-45m-series-b-financing-170616-4926434/ 2016-06-17T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/bausch-lomb-launches-preservision-areds-2-formula-multivitamin-170616-4926444/ 2016-06-17T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/corbus-completes-patient-enrollment-in-phase-2-trial-of-resunab-to-treat-diffuse-cutaneous-systemic-sclerosis-170616-4926670/ 2016-06-17T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/cantabio-university-of-antioquia-partner-to-research-therapeutic-candidates-targeting-dj-1-protein-to-treat-parkinsons-disease-170616-4926708/ 2016-06-17T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/arkin-holdings-phoenix-group-sign-collaboration-deal-to-invest-60m-in-pharma-and-biotech-companies-170616-4926720/ 2016-06-17T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-to-buy-product-portfolio-from-teva-pharmaceutical-industries-170616-4926728/ 2016-06-17T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/european-chmp-grants-orphan-drug-status-to-orbus-eflornithine-brain-cancer-drug-4927202/ 2016-06-20T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/f2g-raises-60m-in-funding-to-progress-antifungal-agents-development-200616-4927641/ 2016-06-20T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-pharmaceuticals-seeks-fda-approval-for-brigatinib-lung-cancer-drug-200616-4927708/ 2016-06-20T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharmaceuticals-unveils-significant-investments-in-canadian-operations-200616-4927718/ 2016-06-20T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/suspending-dosing-with-the-current-clinical-trial-supplies-of-scib1-4927727/ 2016-06-20T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-emergents-slba-for-large-scale-manufacturing-of-biothrax-in-building-55-200616-4927732/ 2016-06-20T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-starts-worlds-first-norovirus-vaccine-field-trial-210616-4928494/ 2016-06-21T02:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/pfizer-selects-oracle-cloud-for-clinical-data-management-and-trial-management-210616-4928927/ 2016-06-21T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-receives-positive-opinion-for-orphan-drug-status-in-eu-for-spear-t-cell-therapy-210616-4929010/ 2016-06-21T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-opens-t-cell-therapy-manufacturing-facility-in-california-210616-4929026/ 2016-06-21T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-triple-copd-combination-therapy-meets-two-co-primary-endpoints-in-phase-iii-study-210616-4929021/ 2016-06-21T06:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/vanc-pharmaceuticals-signs-definitive-deal-for-filing-two-ands-with-exclusive-marketing-rights-to-canada-210616-4929040/ 2016-06-21T06:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cipher-pharmaceuticals-out-licenses-rights-to-asf-1096-for-anorectal-disorders-210616-4929046/ 2016-06-21T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-laboratories-to-buy-generic-products-from-teva-and-allergan-for-586m-220616-4929750/ 2016-06-22T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-selects-infantile-spasms-for-epidiolex-development-program-220616-4930187/ 2016-06-22T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/globaldata-expects-ipf-market-to-more-than-treble-to-32bn-by-2025-220616-4930247/ 2016-06-22T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-treats-first-patient-in-phase-1-trial-of-ucart19-in-pediatric-acute-b-all-220616-4930257/ 2016-06-22T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/orig3n-kangstem-biotech-collaborate-to-study-neural-stem-cells-220616-4930268/ 2016-06-22T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/rich-pharmaceuticals-retains-theradex-systems-to-help-advance-hodgkins-lymphoma-indication-220616-4930277/ 2016-06-22T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/therapix-signs-binding-mou-with-swiss-pharmaceutical-firm-to-receive-license-to-use-formulation-for-ultralow-dosage-administration-220616-4930286/ 2016-06-22T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-epizyme-to-assess-anti-cancer-effects-of-tazemetostattecentriq-combination-230616-4930841/ 2016-06-23T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-anavex-2-73-to-treat-infantile-spasms-230616-4931533/ 2016-06-23T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/collegium-unveils-positive-topline-results-for-hydrocodone-deterx-clinical-study-230616-4931539/ 2016-06-23T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/dimension-gets-national-institutes-of-health-panels-approval-for-phase-12-study-of-dtx301-230616-4931570/ 2016-06-23T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/compugen-discloses-lead-therapeutic-candidate-for-cgen-15029-immuno-oncology-program-230616-4931575/ 2016-06-23T06:25:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/tb-alliance-takeda-partner-to-investigate-novel-compounds-for-tuberculosis-treatment-230616-4931584/ 2016-06-23T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-secures-fda-breakthrough-therapy-for-ruxolitinib-to-treat-acute-gvhd-230616-4931789/ 2016-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-authorities-recommended-against-astrazenecas-flu-vaccine-quadrivalent-230616-4931828/ 2016-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-house-passes-11bn-bill-to-fight-zika-virus-230616-4931873/ 2016-06-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-biomedical-gets-orphan-drug-designation-for-napabucasin-in-gastricgej-cancer-240616-4932582/ 2016-06-24T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-pharma-announces-settlement-of-patent-litigation-for-key-alliance-business-product-240616-4932594/ 2016-06-24T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-acquires-anacor-pharmaceuticals-for-52bn-270616-4933453/ 2016-06-27T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-avodart-capsules-in-us-270616-4933823/ 2016-06-27T05:54:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-committee-recommends-approval-tevas-cinqaero-asthma-drug-270616-4933872/ 2016-06-27T06:15:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gene-editing-firm-crispr-therapeutics-raises-additional-38m-in-series-b-financing-270616-4933906/ 2016-06-27T06:35:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/hengrui-therapeutics-unveils-100m-investment-from-hr-bio-holdings-for-global-clinical-development-270616-4933918/ 2016-06-27T06:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-approves-changes-to-sabril-rems-program-270616-4933927/ 2016-06-27T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-boehringer-ingelheim-to-swap-animal-consumer-health-assets-280616-4934574/ 2016-06-28T02:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ema-committee-recommends-approval-of-mercks-keytruda-for-advanced-nsclc-280616-4935188/ 2016-06-28T06:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gw-pharmaceuticals-epidiolex-succeds-in-late-stage-study-in-lennox-gastaut-syndrome-280616-4935262/ 2016-06-28T06:37:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/allergy-therapeutics-announces-findings-from-meec-dose-range-finding-study-g204-280616-4935271/ 2016-06-28T06:40:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bristol-myers-squibbs-opdivo-gets-fda-breakthrough-therapy-designation-for-advanced-form-of-bladder-cancer-280616-4935286/ 2016-06-28T06:49:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sobis-elocta-approved-in-switzerland-to-treat-haemophilia-a-280616-4935289/ 2016-06-28T06:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/onxeo-advances-development-plan-for-first-in-class-signal-interfering-dna-compound-asidna-280616-4935295/ 2016-06-28T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-and-fda-accept-for-review-roches-ocrevus-for-two-forms-of-multiple-sclerosis-290616-4936065/ 2016-06-29T02:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gilead-sciences-epclusa-gets-fda-approval-to-treat-chronic-hepatitis-c-virus-infection-290616-4936611/ 2016-06-29T06:44:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/two-additional-phase-3-lipid-lowering-trials-of-bococizumab-meet-primary-endpoints-290616-4936643/ 2016-06-29T06:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/kitovs-kit-302-drug-achieves-manufacturing-milestone-ahead-of-planned-nda-filing-with-fda-290616-4936651/ 2016-06-29T06:58:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/intensity-therapeutics-raises-10m-to-fund-clinical-supplies-manufacturing-and-phase-iii-trials-of-int230-6-290616-4936656/ 2016-06-29T07:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/merck-to-develop-next-generation-purification-processes-with-international-vaccine-institute-4936664/ 2016-06-29T07:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/acelrx-pharmaceuticals-completes-patient-enrollment-in-remaining-phase-3-studies-of-arx-04-290616-4936680/ 2016-06-29T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-imbruvica-breakthrough-therapy-designation-for-cgvhd-300616-4937551/ 2016-06-30T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-moderna-partner-to-develop-mrna-based-personalized-cancer-vaccines-300616-4937930/ 2016-06-30T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/heptares-leadxpro-partner-on-powerful-new-approaches-to-gpcr-structure-determination-for-drug-discovery-300616-4937951/ 2016-06-30T05:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/global-blood-therapeutics-starts-phase-2a-study-of-gbt440-in-adolescents-with-sickle-cell-disease-300616-4937961/ 2016-06-30T05:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/clinigen-horizon-pharma-partner-to-start-european-managed-access-program-for-ravicti-oral-liquid-300616-4937967/ 2016-06-30T05:58:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/xcovery-starts-phase-3-trial-of-x-396-in-alk-non-small-cell-lung-cancer-300616-4937982/ 2016-06-30T06:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-declines-to-approve-lipocines-lpcn-1021-testosterone-drug-300616-4938017/ 2016-06-30T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-psioxus-therapeutics-to-study-immuno-oncology-combination-010716-4938646/ 2016-06-30T23:00:00+00:00 https://www.pharmaceutical-business-review.com/news/shires-retinopathy-treatment-fails-to-meet-primary-endpoint-in-phase-2-trial-010716-4938654/ 2016-06-30T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-start-phase-i-oncology-study-with-icos-agonist-antibody-4938687/ 2016-06-30T23:39:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/moberg-pharma-agrees-to-acquire-three-us-otc-brands-from-prestige-brands-010716-4938725/ 2016-06-30T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/orphan-drug-status-granted-for-mereos-bps-804-for-osteogenesis-imperfecta-4938720/ 2016-06-30T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/new-long-range-wireless-technologies-and-user-interface-advances-are-changing-environmental-monitoring-applications-4939203/ 2016-07-01T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-ferrings-firmagon-for-men-with-advanced-hormone-dependent-prostate-cancer-040716-4939607/ 2016-07-04T02:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/allergan-gets-positive-opinion-from-swedish-mpa-for-belkyra-to-treat-patients-with-submental-fullness-040716-4940086/ 2016-07-04T05:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bind-therapeutics-files-motion-for-sale-of-assets-after-accepting-stalking-horse-bid-from-pfizer-040716-4940109/ 2016-07-04T05:48:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/citius-pharmaceuticals-discontinues-suprenza-to-focus-on-core-assets-040716-4940118/ 2016-07-04T05:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/geovax-filing-investigational-new-drug-application-for-hiv-human-clinical-trial-040716-4940134/ 2016-07-04T05:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aeterna-zentaris-orient-europharma-sign-exclusive-license-deal-for-zoptrex-in-taiwan-and-southeast-asia-040716-4940152/ 2016-07-04T05:57:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-divests-two-dermatology-drug-rights-to-leo-pharma-040716-4940190/ 2016-07-04T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-extended-indication-for-amgens-kyprolis-to-treat-relapsed-multiple-myeloma-050716-4940848/ 2016-07-05T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-partners-with-altos-therapeutics-to-develop-atc-1906-for-gastroparesis-treatment-050716-4941295/ 2016-07-05T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-to-araims-ara-290-to-treat-sarcoidosis-050716-4941346/ 2016-07-05T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/alliancepharma-signs-definitive-agreements-to-acquire-three-companies-050716-4941359/ 2016-07-05T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/ab-science-provides-updates-on-marketing-authorization-application-of-masitinib-050716-4941375/ 2016-07-05T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-receives-clinical-milestone-for-start-of-phase-1-trial-with-novel-hucal-antibody-050716-4941468/ 2016-07-05T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/aviragen-therapeutics-gsurf-sign-deal-to-develop-novel-antiviral-therapies-050716-4941756/ 2016-07-05T12:51:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-zinbryta-to-treat-relapsing-forms-of-multiple-sclerosis-050716-4941702/ 2016-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biocryst-receives-additional-niaid-funding-to-advance-development-of-bcx4430-050716-4941755/ 2016-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/intelgenx-redhill-biopharma-sign-deal-with-grupo-juste-for-commercialization-of-rizaport-060716-4941790/ 2016-07-05T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/hanmi-pharmaceutical-expands-technology-partnership-with-medidata-060716-4941808/ 2016-07-05T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/tigenix-licenses-ex-us-rights-for-cx601-stem-cell-treatment-to-takeda-060716-4941818/ 2016-07-06T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/aprecia-pharmaceuticals-signs-30m-debt-financing-agreement-with-hercules-capital-060716-4941820/ 2016-07-06T00:19:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-accepts-cempras-solithera-ndas-to-treat-community-acquired-bacterial-pneumonia-060716-4941822/ 2016-07-06T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-start-phase-iii-trial-to-assess-avelumab-as-first-line-treatment-for-ovarian-cancer-070716-4942529/ 2016-07-07T02:12:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/carmot-therapeutics-establishes-drug-discovery-collaboration-with-genentech-070716-4942998/ 2016-07-07T05:41:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/vertex-and-moderna-partner-to-develop-mrna-therapeutics-for-cystic-fibrosis-070716-4943037/ 2016-07-07T05:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-accepts-revive-therapeutics-ind-of-bucillamine-to-treat-cystinuria-070716-4943046/ 2016-07-07T05:59:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teligent-advances-50m-facility-expansion-in-buena-070716-4943057/ 2016-07-07T06:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mylan-launches-generic-fenoglide-tablets-in-us-070716-4943063/ 2016-07-07T06:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ec-approves-adcetris-as-consolidation-treatment-in-post-transplant-hodgkin-lymphoma-070716-4943099/ 2016-07-07T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/sandozs-enbrel-biosimilar-meets-primary-endpoint-in-psoriasis-trial-080716-4943634/ 2016-07-08T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynxs-vobarilizumab-demonstrates-positive-treatment-effect-in-phase-2b-arthritis-study-080716-4944190/ 2016-07-08T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-places-clinical-hold-on-juno-therapeutics-jcar015-phase-ii-rocket-trial-080716-4944227/ 2016-07-08T05:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/shire-gets-extension-of-market-authorization-in-europe-for-revestive-to-treat-paediatric-patients-with-sbs-080716-4944238/ 2016-07-08T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/sprint-bioscience-collaborates-with-us-drug-development-firm-on-tumor-metabolism-program-080716-4944254/ 2016-07-08T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/grant-funding-secured-to-explore-midatechs-gold-nanoparticle-technology-in-immunotherapy-080716-4944275/ 2016-07-08T05:25:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/uks-nice-approves-pfizers-bosulif-for-chronic-myeloid-leukaemia-080716-4944346/ 2016-07-08T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-sutent-meets-primary-endpoint-in-phase-3-kidney-cancer-trial-110716-4945242/ 2016-07-11T03:08:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gilead-secures-ec-marketing-authorization-for-epclusa-to-treat-all-genotypes-of-chronic-hepatitis-c-110716-4945592/ 2016-07-11T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/galderma-secures-fda-approval-for-differin-gel-as-otc-treatment-for-acne-110716-4945612/ 2016-07-11T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-forms-process-development-and-manufacturing-collaboration-with-alligator-110716-4945632/ 2016-07-11T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-completes-ccp-08-pivotal-multiple-dose-comparative-bioavailability-study-110716-4945649/ 2016-07-11T06:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/moberg-pharma-completes-acquisition-of-us-otc-brands-from-prestige-brands-110716-4945661/ 2016-07-11T06:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/funds-advised-by-apax-partners-agree-to-buy-operating-subsidiaries-of-invent-farm-110716-4945717/ 2016-07-11T06:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-grants-abbvies-abt-414-rare-pediatric-disease-designation-to-treat-dipg-pediatric-brain-tumor-120617-4946609/ 2016-07-12T03:16:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cytrx-unveils-initial-results-of-phase-3-trial-of-aldoxorubicin-in-patients-with-second-line-sts-120717-4947090/ 2016-07-12T06:19:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/celldex-therapeutics-starts-phase-12-trial-of-cdx-014-in-advanced-renal-cell-carcinoma-120717-4947099/ 2016-07-12T06:23:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cantabio-signs-deal-with-prf-to-advance-development-work-on-targeting-dj-1-protein-small-molecule-pharmaceutical-chaperone-drug-candidates-120717-4947116/ 2016-07-12T06:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/us-fda-grants-orphan-drug-designation-for-mazindol-to-treat-narcolepsy-120717-4947132/ 2016-07-12T06:35:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/evotec-antruk-collaborate-to-discover-antibiotic-resistance-breakers-120716-4947178/ 2016-07-12T06:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/x-chem-bayer-expand-drug-discovery-collaboration-130716-4948169/ 2016-07-13T03:46:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sapience-therapeutics-raises-225m-in-series-a-financing-130716-4948580/ 2016-07-13T06:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/130716seres-therapeutics-emulate-collaborate-to-support-development-of-novel-microbiome-therapeutics-4948591/ 2016-07-13T06:14:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aphios-secures-subcontract-for-nanoformulation-of-super-hydrophobic-anticancer-drug-130716-4948601/ 2016-07-13T06:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/amgen-to-discuss-data-supporting-abp-501-bla-with-fda-130716-4948617/ 2016-07-13T06:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/shires-xiidra-secures-fda-approval-for-dry-eye-disease-130716-4948671/ 2016-07-13T06:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sage-therapeutics-postpartum-depression-drug-demonstrates-positive-results-in-phase-2-trial-130716-4948713/ 2016-07-13T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-boehringer-ingelheim-form-clinical-trial-partnership-in-metastatic-breast-cancer-140716-4949338/ 2016-07-14T02:07:00+00:00 https://www.pharmaceutical-business-review.com/news/roivant-sciences-plexcera-therapeutics-establish-new-biopharmaceutical-firm-enzyvant-sciences-140716-4949647/ 2016-07-14T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-daiichi-sankyo-sign-deal-to-commercialize-biosimilars-in-japan-140716-4949659/ 2016-07-14T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/aptinyx-starts-dosing-in-phase-1-study-of-lead-nmda-receptor-modulator-nyx-2925-140716-4949683/ 2016-07-14T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/intelgenx-starts-phase-1-clinical-trial-of-montelukast-140716-4949704/ 2016-07-14T04:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-sandoz-resolve-faslodex-patent-litigation-in-us-140716-4949889/ 2016-07-14T05:48:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/redhill-biopharma-announces-research-collaboration-with-nih-for-potential-ebola-treatment-140716-4949907/ 2016-07-14T05:53:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/abzena-and-us-research-institute-form-immunotherapy-joint-venture-150716-4950771/ 2016-07-15T02:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/juno-therapeutics-acquires-boston-based-redoxtherapies-150716-4951176/ 2016-07-15T05:41:00+00:00